Formulary

Report : A-Z of formulary items 13/04/2021 14:54:39

Section	Name	Details
10.01.03	Abatacept Orencia^®	Intravenous infusion 250mg vial Injection 125mg pre-filled syringe
02.09	Abciximab	Injection - Restricted for stents only
08.03.04.02	Abiraterone Zytiga^®
04.10.01	Acamprosate Campral EC^®	Tablet 333mg Usual dose range: Bodyweight OVER 60Kg 666mg TDS, Bodyweight UNDER 60Kg 666mg breakfast, 333mg midday and 333mg at night
06.01.02.03	Acarbose Glucobay^®	Tablet50mg 100mg Useful in the occasional overweight patient but limited by gastrointestinal intolerance
02.08.02	Acenocoumarol	Tablet Only used for those patients intolerant of warfarin and phenindione, or existing patients
20	Acetarsol Suppositories	FORM AND STRENGTH: Suppository 250mg INDICATION: Drug resistant proctitis DOSE: 250mg twice daily PACK SIZE: SUPPLIER: Cardinal Health Martindale LICENSE TYPE: UK unlicensed specials manufacturer PRESCRIBING CONSULTANT: Dr C Kenneth DATE AUTHORISED: 16/03/2012
11.06	Acetazolamide Diamox^®	Tablets 250mg, Capsules MR 250mg
11.08.02	Acetylcholine Chloride Miochol-E^®
03.07	Acetylcysteine
11.08.01	Acetylcysteine
18	Acetylcysteine Parvolex
20	ACETYLCYSTEINE 10% PRESERVATIVE FREE	FORM AND STRENGTH: 10% preservative free eye drops INDICATION: Severe dry eyes SUPPLIER: Moorfields Pharmaceuticals PRESCRIBING CONSULTANT: Dr A Reynolds DATE AUTHORISED: 26/07/2012
11.08.01	Acetylcysteine 5% with Hypromellose 0.35% Ilube^®	Eye drops
20	ACETYLCYSTEINE granules	FORM AND STRENGTH: Granules 1g, capsules 600mg INDICATION: Idiopathic Pulmonary Fibrosis SUPPLIER: IDIS PRESCRIBING CONSULTANT: Dr B Jacobs DATE AUTHORISED: Granules 20/12/2005, Capsules 13/06/2007
05.03.02.01	Aciclovir
13.10.03	Aciclovir
24.01	Aciclovir	Indication: Herpes zoster, treatment Varicella zoster, treatment Dose: 20mg/kg every 8 hours For further information see Y&H ODN formulary - Scroll to top Administration: See Medusa IV guide for infomation on administration - Scroll to top Monitoring: Renal function Further Info: Maintain adequate hydration Supply: Available on NNU as a stock item.
11.03.03	Aciclovir eye ointment Zovirax^®	Eye ointment 3%
13.05.02	Acitretin Neotigason^®	Capsule 10mg, 25mg Dermatology specialist only
20	Acitretin oral suspension	FORM AND STRENGTH: 1mg/ml oral suspension INDICATION: Harlequin Icthyosis SUPPLIER: Novo labs 0116 2230099 PRESCRIBING CONSULTANT: Dr Heike Bauer (17/05/2007) and Dr Chris Day (20/01/2010)
03.01.02	Aclidinium Eklira Genuair^®	Inhalation powder inhaler (400 micrograms/dose)
18	Activated charcoal
06.01.01.01	Actrapid^® Soluble insulin	Short acting human soluble insulin 10mL vial
01.05.03	Adalimumab Amgevita	Amgevita is the brand of choice at BTHFT, Humira can only be prescribed if approved by DTC. TA187: Infliximab and adalimumab for the treatment of Crohn's disease TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
10.01.03	Adalimumab Amgevita	Amgevita is brand of choice at BTHFT. Humira should only be prescribed if approved to do so by DTC. To be prescribed as per NICE guidelines: NICE TA 375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed NICE TA 373 - Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis NICE TA 195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor NICE TA 199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis Monitoring guidance can be found: Yorkshire DMARD Guidelines
13.05.03	Adalimumab Amgevita	TA146: Adalimumab for the treatment of adults with psoriasis TA187: Infliximab and adalimumab for the treatmetn of Crohn's disease TA199: Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa TA455:Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people TA460: Adalimumab and dexamethasone for treating non-infectious uveitis
13.05.03	Adalimumab Amgevita	Amgevita is brand of choice at BTHFT. Humira should only be prescribed if approved to do so by DTC. To be prescribed as per NICE guidelines: TA199: Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA146: Adalimumab for the treatment of adults with psoriasis TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
13.06.01	Adapalene Epiduo^®	Contains adapalene 0.1% and benzoyl peroxide 2.5% Gel
13.06.01	Adapalene Differin^®	Cream and Gel
09.06.04	Adcal D3 Dissolve^®	Colecalciferol 400 units + calcium carbonate 1500mg per tablet For patients who cannot chew or swallow tablets or for giving via an enteral tube
09.06.04	Adcal D3^®	Colecalciferol 400 units (10 micrograms) + calcium carbonate 1500mg (calcium 600mg) per tablet
09.06.04	Adcal D3^® Caplets	Colecalciferol 200 units (5 micrograms) + calcium carbonate 750mg (calcium 300mg) per caplet For patients who cannot tolerate Adcal D3 chewable tablets but can swallow tablets
05.03.03	Adefovir Dipivoxil Hepsera^®
02.03.02	Adenosine	Injection Secondary care only
24.01	Adrenaline	Indication Acute hypotension Dose Consider starting at 0.1micrograms/kg/min. Higher doses up to 1.5 micrograms/kg/minute have been used in acute hypotension For further information see Y&H ODN formulary - Scroll to top Administration Continuous IV infusion via central line. USE GUARDRAILS ON INFUSION PUMP Syringe concentration - 3000 microgram in 50 ml 5% or 10% glucose. (60micrograms/ml) Monitoring BP, Heart rate, Peripheral perfusion, Blood sugars, Blood gas Further Info CHECK STRENGTH OF AMPOULE! See " Cardiovascular support in neonates" guideline Supply Available from pharmacy as a stock item as vials. DSU can make named patient syringes on request during normal working hours. Contact ward pharmacist
02.07.03	Adrenaline / Epinephrine	Injection Adult dose is 10ml of 1:10,000 given IV (Note: For anaphylaxis the dose is 0.5ml of 1:1,000 given IM ).
03.04.03	Adrenaline / Epinephrine	Injection Treatment of anaphylaxis
03.04.03	Adrenaline / Epinephrine
03.04.03	Adrenaline / epinephrine EpiPen^®	Treatment of anaphylaxis
08.01.05	Afatinib
08.01	Aflibercept Zaltrap^®
11.08.02	Aflibercept Eylea^®	Intravitreal injection
04.03.04	Agomelatine	Tablets 25mg Usual dose range 25-50mg daily Max daily dose 50mg Max single dose 50mg
09.02.02.02	Albumin Solution
13.11.01	Alcohol
06.06.02	Alendronic Acid	Tablet 70mg 70mg once WEEKLY dose
06.06.02	Alendronic acid Binosto^®	Restricted for use in patients with true swallowing difficulties (e.g. strictures) or those truly intolerant of bisphosphonate tablets despite the addition of a PPI.
09.06.04	Alfacalcidol
15.01.04.03	Alfentanil
09.08.01	Alglucosidase Alfa Myozyme^®
02.12	Alirocumab Praluent^®	For use in line with NICE TA393
02.05.05.03	Aliskiren	Tablet for specialist cardiology initation only
13.05.01	Alitretinoin Toctino^®	Capsules Dermatology specialist use only Restricted to use in adult patients with severe chronic hand eczema unresponsive to treatment with potent topical corticosteroids in accordance with NICE TAG 177.
10.01.04	Allopurinol Zyloric^®
10.01.04	Allopurinol
09.06.05	Alpha Tocopheryl Acetate
07.04.05	Alprostadil Caverject^®	Intracavernosal Injection
07.04.05	Alprostadil MUSE^®	Urethral application
24.01	Alprostadil Prostin VR	Indication: Open/maintain patency of the ductus arteriosus Dose: 12.5-100 nanograms/kg/min But higher doses may be used e.g. 200 nanograms/kg/min If well start at 12.5 or 25 nanograms/kg/min Unwell babies with ?duct dependent problem expect to need ventilation, start at 100nanograms/kg/min See regional guidance link Administration USE GUARDRAILS ON INFUSION PUMP Syringe concentration - 300micrograms in 50ml in 5% glucose See guide line in link below for more infomation. Monitoring Watch for apnoea(especially in U&E, bloods sugars, reflux. Further Info: See Y&H ODN guidline in link below Undiluted solution must NOT come into contact with the barrel of the plastic syringe; add the required volume of alprostadil to a volume of infusion fluid in the syringe and then make up to final volume. Supply: Available on NNU as a stock item. Stored in fridge. Available from Pharmacy DSU on named patient request during normal hours. Contact ward pharmacist
02.10.02	Alteplase	Injection (secondary care only) Actilyse^® Actilyse Cathflo^®. For thrombolytic treatment of occluded venous access devices only
11.99.99.99	Alteplase intravitreal injection	Intravitreal injection 25microgram in 0.1mL
13.12	Aluminimum Chloride Hexahydrate 20% in Alcoholic Base Driclor^®
13.12	Aluminimum Salts
01.02	Alverine Citrate Spasmonal^®	Capsules, 60mg and 120mg (forte)
04.09.01	Amantadine Hydrochloride Symmetrel^®
05.01.04	Amikacin
24.01	Amikacin	Indication: Gentamicin resistant gram negative bacilli Dose: 15mg/kg 36 hourly in babies < 32 weeks 15mg/kg 24 hourly for all other neonates and infants 20mg/kg may be needed in severe sepsis Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function The target trough is <5mg/L Sample should be taken 6 hours prior to 3rd dose. Repeat daily until stable, then every 3 doses. Redose patient at 24 hours if trough level achieved. If trough is high, recheck level 12 hours after that level was taken and redose after that if level in range. Further Info: Nephrotoxicity may be increased by concurrent administration of amphotericin and potent diuretics. Supply: Available from pharmacy on a named patient request.
02.02.03	Amiloride Hydrochloride	Tablet 5mg, Oral solution 5mg/5ml Tablets can be crushed and dispersed in water if necessary
03.01.03	Aminophylline Phyllocontin Continus^®	Tablets M/R 225mg 350mg tablets not stocked at BTHFT
03.01.03	Aminophylline IV	Injection, 25mg/ml
02.03.02	Amiodarone	Tablet, Injection (secondary care only) Tablets can be crushed and mixed with water
04.02.01	Amisulpride
04.03.01	Amitriptyline
02.06.02	Amlodipine	Tablet If needed tablets can be crushed and dispersed in water. Amlodipine Oral Solution restricted for those patients with established swallowing difficulties or NG tube administration
13.10.02	Amorolfine Loceryl^®
05.01.01.03	Amoxicillin
24.01	Amoxicillin	Indication Infection - broad spectrum Dose IV:30-60 mg/kg/dose every 12 hours <7 days of age IV:30-60/kg/dose every 8 hours >7 days of age Oral: 30mg/kg/dose every 8 hours >7days of age Administration See Medusa IV guide for information on administration - Scroll to top IV doses over 30mg/kg to be given by IV infusion over 30minutes Monitoring Renal function Further Info: Active againist: listeria, haemophyllus, enterococci, streptococci, pneumococci, salmonella,shigella and many coliforms Supply: Available on NNU as a stock item. Oral to be ordered on a named patient request.
05.02	Amphotericin AmBisome^®
24.01	Amphotericin (liposomal) Ambisome^®	Indication Systemic fungal infections Dose All ages, give a test dose of 100microgram/kg, to a maximum of 1mg, over 10 minutes. Maintenence dose can be given 1 hour after test dose. 1mg/kg once a day, increased if necessary, to 3mg/kg once a day. Administration IV infusion over at least 30 minutes. Amphotericin MUST be diluted in Glucose 5% for infusion. Final concentration in neonates must be 1mg/ml Lines MUST be flushed with Glucose 5% ONLY. A test dose of 100micrograms over 10 minutes may be considered in older babies to reduce risk of anaphaylaxis. See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function Potassium Further Info Prescribe as “Amphotericin liposomal (AmBisome)” Active against aspergillosis, candidasis, coccidoidomycosis and cryptococcosis. Supply: Vials are available from pharmacy as a named patient supply.
08.01.05	Amsacrine Amsidine^®
09.01.04	Anagrelide	Capsule On Haematologist advice only.
10.01.03	Anakinra Kineret^®	Prefilled syringe 100mg (subcut) Daily dose
08.03.04.01	Anastrozole
12.03.01	Antacid with Oxetacaine	Each 5ml contains 10mg Oxetacaine, Aluminium hydroxide equivalent to 200mg aluminium oxide + 100mg magnesium hydroxide Indicated for painful swallowing, during and following radiotherapy to the head & neck and chest areas. Should be reserved for patients with oral mucositis and oesophageal lesions which are causing painful swallowing. Consider the use of a simple antacid first line.
11.04.02	Antazoline 0.5% with Xylometazoline 0.05% Otrivine-Antistin^®
14.05.03	Anti-D (Rh₀) Immunoglobulin Rhophylac^®
08.02.02	Anti-human thymocyte immunoglobulin (rabbit) Thymoglobuline^®
01.07.01	Anusol^®	Ointment, Cream, Suppositories
02.08.02	Apixaban	Tablets 2.5mg amd 5mg POSITION STATEMENT TO ADD
04.09.01	Apomorphine
11.08.02	Apraclonidine Iopidine^®
08.02	Apremilast Otezla^®	For use in line with NICE TA419
13.05.03	Apremilast Otezla	Oral tablets As per NICE guidelines: TA419:Apremilast for treating moderate to severe plaque psoriasis TA433: Apremilast for treating active psoriatic arthritis
04.06	Aprepitant Emend^®	Capsules For oncology patients only
13.02.01	Aqueous Cream BP	Cream Not recommended for use in children Only use a soap substitute, not as a moisturiser
04.02.01	Aripiprazole Abilify^®	Tablet Dispersible tablets Liquid Injection (IM use) Injection (prolonged release suspension for injection)
08.01.05	Arsenic Trioxide Trisenox^®
15.02	Articaine Hydrochloride with Adrenaline Septanest^®
09.06.03	Ascorbic Acid	Tablets 50mg, 100mg, 200mg, 500mg
04.07.01	Aspirin	Tablet dispersible and E/C, 75mg and 300mg, Suppository
02.09	Aspirin (antiplatelet)	Tablets - dispersible and EC, (Suppository - Named patient use) Enteric coated aspirin is second line to dispersible aspirin in line with UKMI Q&A below For recommendation for use of aspirin in pregnant women at high risk of pre-eclampsia see NICE CG107.
05.03.01	Atazanavir Reyataz^®	specialist consultant
02.04	Atenolol	Tablet, Liquid, (Injection - secondary care only)
04.04	Atomoxetine Strattera^®	Capsules 10mg and 40mg Drug treatment of attention deficit hyeractivity disorder (ADHD) Usual dose range 80mg-100mg Max daily dose 120mg (unlicensed) Max single dose 120mg (unlicensed)
02.12	Atorvastatin	Tablets If needed tablets can be crushed and dispersed in water
07.01.03	Atosiban Tractocile^®	Injection 7.5mg/ml
24.01	Atracurium	Indication: Short acting muscle relaxant Dose A 500microgram/kg stat dose can produce muscle relaxation for up to 30 mins. A continuous infusion of 300-500micrograms/kg/hour will provide continual neuromuscular blockade in neonates. Some mat need Administration USE GUARDRAIL INFUSION PUMP Syringe Concentration 25mg in 25mls (1mg/ml). Infusions made up in glucose 5% need to be made up every 8 hours, while those in sodium chloride 0.9% can be changed every 24 hours. See Medusa IV guide for information on administration - Scroll to top Monitoring U&E, temperature, Further Info: In babies requiring paralysis consider sedation and pain relief were necessary. Supply: Available from pharmacy as a stock item. Stored in fridge
15.01.05	Atracurium Besilate
15.01.05	Atracurium Besilate Tracrium^®
15.01.03	Atropine
18	Atropine
11.05	Atropine Sulphate	Eye drops 0.5% and 1%, Minims 1%
10.01.03	Auranofin Ridaura^®
07.04.05	Avanafil Stendra^®
13.02.01	Aveeno^®	Cream, Bath oil
08.01.03	Azacitidine Vidaza^®
01.05.03	Azathioprine	Tablets 25mg, 50mg, Suspension SF 50mg/5ml
08.02.01	Azathioprine
10.01.03	Azathioprine
13.05.03	Azathioprine	Oral treatment SWYAPC shared care guidelines
11.04.02	Azelastine Optilast^®	Eye drops 0.05%
05.01.05	Azithromycin
11.03.01	Azithromycin Azyter^®	eye drops single use 1.5%
24.01	Aztreonam	Indication Infection- limited to Gram-negative aerobic bacteria Pseudomonas aeruginosa, Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenza. Dose 30 mg/kg/dose every 12 hours in preterm 30 mg/kg/dose every 8 hours in term <7days 30 mg/kg/dose every 6-8 hours in term neonates >7days Reduce dose in renal impairment see additonal resources for dose adjustment. Administration See Medusa IV guide for information on administration - Scroll to top Monitoring U&E, LFT, FBC Further Info: Supply: Available from pharmacy on named patient request.
05.01.02.03	Aztreonam nebuliser solution Cayston^®
10.02.02	Baclofen
12.02.03	Bactroban Nasal^® Mupirocin 2% in White Soft Paraffin	Nasal ointment July 2014 - ongoing manufacturing problem - use naseptin as an alternative (check for peanut allergy) MRSA suppression: Three times daily for 5 days
01.05.01	Balsalazide Sodium Colazide^®	Capsules 750mg
13.02.02	Barrier preparation Metanium^®
13.02.02	Barrier preparation Siopel^®	Cream
13.02.02	Barrier preparation Sudocrem^®
08.02.04	BCG bladder instillation OncoTICE^®
14.04	BCG vaccine Intradermal
03.02	Beclometasone Clenil Modulite^®	Aerosol Inhaler Available strengths 50mcg/dose, 100mcg/dose, 200mcg/dose and 250mcg/dose
03.02	Beclometasone Qvar^®	Aerosol and Breath-actuated inhaler Prescribe by brand Aerosol 50mcg/dose, 100mcg/dose Easi-breathe 50mcg/dose, 100mcg/dose Autohaler not stocked within BTHFT Qvar is not interchangeable with other CFC-free beclometasone inhalers, Qvar is approximately twice as potent as Clenil
03.02	Beclometasone and formoterol Fostair^®	Aerosol Inhaler Beclometasone 100 micrograms and formoterol 6 micrograms
12.02.01	Beclometasone Dipropionate	Nasal spray 50micrograms per spray
03.02	Beclometasone with formoterol and glycopyrronium Trimbow^®	Trimbow 87/5/9 MDI
08.01.01	Bendamustine
02.02.01	Bendroflumethiazide	Tablet 2.5mg If needed tablets can be dispersed in water
20	BENZBROMARONE Tablets 100 mg, 50mg	FORM AND STRENGTH: 100mg Tablet INDICATION: Gout where intolerant/allergic to allopurinol and febuxostat DOSE: 100mg daily PACK SIZE: SUPPLIER: IDIS LICENSE TYPE: Licensed in Germany PRESCRIBING CONSULTANT: Dr Helen McIver (13/11/2013)
13.06.01	Benzoyl Peroxide
13.06.01	Benzoyl Peroxide 5% with Clindamycin 1% Duac^® Once Daily	Cream
12.03.01	Benzydamine Difflam^®	Oral rinse, Spray
05.01.01.01	Benzylpenicillin Crystapen^®
05.01.01.01	Benzylpenicillin Benzathine
24.01	Benzylpenicillin Sodium	Indication Empirical treatment of early onset neonatal sepsis. Active againist streptococcal(including pneumococcal), gonococcal, and meningococcal infections Dose 50 mg/kg/dose every 12 hours 50 mg/kg/dose every 8 hours 7-28 days 50 mg/kg/dose every 6 hours >28 days For further information see Y&H ODN formulary - Scroll to top Administration Slow IV bolus or infusion over 15–30 minutes. Longer administration time is particularly important when using doses of 50 mg/kg (or greater) to avoid CNS See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function Further Info Consider reducing dose to 25mg/kg/dose in moderate to severe renal failure. Seek senior advice. Supply: Available from pharmacy as a stock item
04.06	Betahistine Dihydrochloride	Tablet 8mg and 16mg If needed tablets can be crushed and dispersed in water. More Info
13.04	Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic^®	Ointment, scalp lotion Potent For thick plaque psoriasis
13.04	Betamethasone (as Valerate) 0.025% Betnovate-RD^®	Cream, Ointment Moderate
13.04	Betamethasone (as Valerate) 0.1% Betnovate^®	Cream, Ointment, Scalp application, Lotion Potent
13.04	Betamethasone (as Valerate) 0.1% with Clioquinol Betnovate-C^®	Ointment, Cream Potent with antimicrobial Now available generically but more expensive than before approx £19 for 30g
13.04	Betamethasone (as Valerate) 0.1% with Neomycin Sulphate 0.5% Betnovate-N^®
12.01.01	Betamethasone 0.1% with Neomycin 0.5% ear drops
11.04.01	Betamethasone 0.1% with Neomycin 0.5% eye drops Betnesol N^®	Drops - Can be used for eye,ear and nose
12.01.01	Betamethasone ear drops	Drops 0.1%
11.04.01	Betamethasone eye ointment Betnesol^®	Eye ointment 0.1%
11.04.01	Betamethasone eye, ear, nose drops Vistamethasone^®	Drops 0.1%- for the eye, ear & nose
12.02.01	Betamethasone nasal drops	Drops 0.1%
11.06	Betaxolol Betoptic^®	0.5% Eye drops
08.01.05	Bevacizumab Avastin^®
11.08.02	Bevacizumab intravitreal injection Avastin^®
02.12	Bezafibrate	Immediate release tablets, 200mg Modified release tablets, 400mg
08.03.04.02	Bicalutamide
11.06	Bimatoprost Lumigan^®	Eye drops 0.01% and 0.03% For those patients where pressure reduction has been inadequate on latanoprost
11.06	Bimatoprost with Timolol Ganfort^®	Eye drops
09.08.01	Biotin
06.01.01.02	Biphasic Insulin Aspart NovoMix^® 30	10mL vial, 3mL cartridge, 3mL prefilled pen
06.01.01.02	Biphasic Insulin Lispro Humalog^® Mix	Available as Mix25 and Mix50. 3mL cartridge, 3mL prefilled pen (KwikPen)
06.01.01.02	Biphasic Isophane Insulin Hypurin^® Porcine 30/70 Mix
06.01.01.02	Biphasic Isophane Insulin Humulin^® M3	10mL vial, 3mL cartridge, 3mL prefilled pen First choice in type II diabetes
06.01.01.02	Biphasic Isophane Insulin Insuman^® Comb	Available as Comb 15, Comb 25, and Comb 50
01.06.02	Bisacodyl	Tablet e/c 5mg, Suppository 10mg
02.04	Bisoprolol	Tablet First line use for heart failure If needed tablets can be crushed and dispersed in water
02.08.01	Bivalirudin	Injection (secondary care only) Restricted to use in accordance with NICE TAG 230 and CG94. Consultant recommendation only.
08.01.02	Bleomycin
08.02.03	Blinatumomab Blincyto^®	For use in line with NICE TA450
05.03.03	Boceprevir Victrelis^®
13.08.01	Borderline Substances Anthelios^®	Cream Highest UVA/UVB protection Preservative and perfume free
08.01.05	Bortezomib Velcade^®
08.01.05	Bosutinib Bosulif^®
04.09.03	Botulinum Toxin Type A Botox^®	Prescribe by brand Units are not equivalent
04.09.03	Botulinum Toxin Type A Dysport^®	Prescribe by brand Units are not equivalent
04.09.03	Botulinum Toxin Type A Xeomin^®
08.01.05	Brentuximab vedotin Adcetris^®	To be used in line with NICE guidance
11.06	Brimonidine Tartrate	Eye drops 0.2%
11.06	Brimonidine Tartrate 0.2% with Timolol 0.5% Combigan^®	Eye drops
11.06	Brinzolamide Azopt^®	Eye drops 10mg/ml
11.06	Brinzolamide 1% with Timolol 0.5% Azarga^®	Eye drops
13.05.03	Brodalumab Kyntheum	To be prescribed as per NICE guidelines: TA511: Brodalumab for treating moderate to severe plaque psoriasis
04.09.01	Bromocriptine
06.07.01	Bromocriptine	Tablets 1mg and 2.5mg
01.05.02	Budesonide Budenofalk^®	3mg gastro resistant capsules
01.05.02	Budesonide Cortiment	Cortiment 9mg prolonged release tablets Once daily preparation
01.05.02	Budesonide Jorveza^®	1mg orodispersible tablet Restricted for use by gastroenterology only for eosinophilic oesophagitis
01.05.02	Budesonide Entocort^®	3mg modified release capsules
03.02	Budesonide Pulmicort^®	Dry powder inhaler, Nebules Pulmicort turbohaler stocked at BTHFT, 100mcg/dose and 200mcg/dose Easyhaler brand not stocked Nebules 500mcg/2ml and 1mg/2ml
12.02.01	Budesonide	Nasal spray 64micrograms per spray
03.02	Budesonide and formoterol Symbicort^®	Dry powder inhaler (Turbohaler)
02.02.02	Bumetanide	Tablet 1mg and 5mg, Liquid 1mg/5ml, Liquid - very expensive. Tablets can be crushed and mixed with water as an alternative. Injection 0.5mg/ml - no longer available, use furosemide IV if necessary 1 mg oral bumetanide is roughly equivalent to 40 mg oral furosemide
15.02	Bupivacaine Hydrochloride
15.02	Bupivacaine with Fentanyl
04.07.02	Buprenorphine BuTrans^® patch	Patch (Weekly patch) Only for patients where other options eg codeine, tramadol or low dose morphine have been exhausted. Morphine preferred if a strong opioid needed. When compared to other opiates Butrans® patches are weak and expensive
04.07.02	Buprenorphine Temgesic^®
04.07.02	Buprenorphine Transtec^® patch	Patch Change every 4 days (96 hours)
04.10.03	Buprenorphine Subutex^®	Sublingual tablets 400mcg, 2mg and 8mg Substance misuse Usual dose range 2-24mg Always confirm with patients substance misuse service or regular community pharmacy to confirm the dose before prescribing. Contact details for Bradford Substance Misuse: Bradford Substance Misuse Directory
04.10.03	Buprenorphine and Naloxone Suboxone^®	Sublingual Tablets 2mg/0.5mg and 8mg/2mg Substance misuse Usual dose range 2-24mg Always confirm with patients substance misuse service or regular community pharmacy to confirm the dose before prescribing. Contact details for Bradford Substance Misuse: Bradford Substance Misuse Directory
04.10.02	Bupropion Hydrochloride Zyban^®
08.03.04.02	Buserelin
08.01.01	Busulfan
03.04.03	C₁ Esterase Inhibitor Berinert^®
03.04.03	C1 esterase inhibitor Cinryze^®
08.01.05	Cabazitaxel Jevtana^®	Available Via CDF for following 2nd line treatment of advanced castration resistant prostate cancer following docetaxel based regimen 3rd line treatment of advanced castration resistant prostate cancer following docetaxel and abiraterone based treatment
04.09.01	Cabergoline
06.07.01	Cabergoline	Tablets 500microgram
24.01	Caffeine CITRATE	Indication Neonatal apnoea Dose Loading - 20mg/kg once a day. IV to be given over 30min Maintenance - 10 mg/kg once a day. IV to be given over 10min. IV = PO dose Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Levels (not routinely needed) 75-150 mmol/litre Further Info Prescribed as CAFFEINE CITRATE only Supply Available from pharmacy as stock item
13.03	Calamine	lotion, with aqueous cream
13.05.02	Calcipotriol Dovonex^®
13.05.02	Calcipotriol 50micrograms/g with Betamethasone 0.05% Dovobet^®	Gel, Ointment
06.06.01	Calcitonin (salmon) / Salcatonin	Injection
09.06.04	Calcitriol
13.05.02	Calcitriol 3micrograms/g Silkis^®
09.05.02.02	Calcium Acetate Phosex^®	Tablets Generally recommended as first line phosphate binder. More effective than calcichew and less elemental calcium.
09.05.02.02	Calcium Carbonate	Tablets Calcium-based phosphate binders may be used as the initial binder therapy for patients with chronic kidney disease as they are cheap and relatively efficacious, in conjunction with dietary phosphate restriction, to control phosphorus and parathyroid levels. If hypercalcaemia develops with the use of calcium carbonate, it may be necessary to convert to calcium acetate, a non calcium-containing phosphate binder, or a combination of both.
09.05.01.01	Calcium carbonate with calcium lactate gluconate Calvive	Calvive 1000 effervescent tablets (replacement for Sandocal) Electrolyte guidelines available here
09.05.01.01	Calcium Chloride	Injection 10% Acute treatment of hypocalcaemia, see local guidance
08.01	Calcium Folinate
09.05.01.01	Calcium Gluconate	Injection 10% Ca2+ approx 225micromol/ml
24.01	Calcium Gluconate	Indication Acute hypocalcaemia Dose Urgent correction 0.46 mmol/kg (2 mL/kg calcium gluconate 10%) for hypocalcaemia Maintenance 0.5 to 1mmol/kg daily, adjusted according to response, dose to be given over 24 hours, use oral route as soon as possible due to risk of extravasation. Administration See Medusa IV guide for information on administration - Scroll to top USE GUARDRAILS ON INFUSION PUMP Syringe Concentration 2.25mmol Ca in 50mL (0.045mmol/mL) Monitoring Potassium, Calcium and Phosphate Further Info Use PN "Side order" guideline for making continious infusion - search link below. Storage & Supply Available on NNU as a stock item
09.05.02.02	Calcium salts with magnesium carbonate Osvaren^®
09.05.01.01	Calcium-Sandoz^®	Syrup - CURRENT SUPPLY ISSUES ALTERNATIVES INCLUDE CACIT EFFERVESCENT TABLETS AND SANDOCAL calcium glubionate 1.09 g, calcium lactobionate 727 mg (calcium 108.3 mg or Ca2+ 2.7 mmol)/5 mL
02.05.05.02	Candesartan	Tablets If needed tablets can be crushed and dispersed in water
13.09	Capasal^®
08.01.03	Capecitabine Xeloda^®
04.07.03	Capsaicin
10.03.02	Capsaicin Zacin^®
10.03.02	Capsaicin Qutenza^®
02.05.05.01	Captopril	Tablet, Liquid (5mg/ml and 25mg/ml If needed tablets disperse in water. Flush enteral tubes well after administration. NB: Absorption may be reduced if given via enteral tube that terminates in the jejunum.
24.01	Captopril	Indication Congestive cardiac failure and hypertension Dose Initailly a test dose 10 microgram/kg, If tolerated increasing to max dose of 100microgram/kg/dose every 8 hours. Older babies usually require a larger dose. Discuss with Paediatric Cardiology. Administration Oral - Liquid Monitoring Close monitoring of blood pressure essential every 1-2 hour after test dose. Montior blood pressure regulary when on maintenance regime. Renal function Further Info Also used to reduce proteinuria in nephrotic syndrome Supply: Available from pharmacy on named patient request.
04.02.03	Carbamazepine	Tablets 100mg, 200mg, 400mg Slow relase preparations also available Liquid 100mg/5ml Usual dose range 400mg-600mg two to three times daily Max daily dose 1600mg
04.07.03	Carbamazepine
04.07.03	Carbamazepine
04.08.01	Carbamazepine
04.08.01	Carbamazepine Tegretol^®
04.08.01	Carbamazepine Carbagen^® SR
04.08.01	Carbamazepine Tegretol^® Retard
06.02.02	Carbimazole Neo-Mercazole^®	Tablets 5mg and 20mg
03.07	Carbocisteine	Capsules 375mg, Liquid 125mg/5ml and 250mg/5ml
11.08.01	Carbomer 980 eye drops	Viscous eye drops (gel)
08.01.05	Carboplatin
07.01.01	Carboprost Hemabate^®	Injection- secondary care only
09.08.01	Carglumic Acid Carbaglu^®
11.08.01	Carmellose	Eye drops - unit dose 0.5% and 1% Xailin Fresh formulary product for 0.5% unit dose drops
08.01.01	Carmustine BiCNU^®
08.01.01	Carmustine Gliadel^®
09.08.01	Carnitine Carnitor^®
A2.05.02	Carobel, Instant^®	For use in infants under 1 year
02.04	Carvedilol	Tablet
07.04.04	Catheter Patency Solutions	Sodium chloride 0.9% Solution G
05.01.02.01	Cefaclor
05.01.02.01	Cefalexin
05.01.02.01	Cefotaxime
24.01	CefoTAXime	Indication: Severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria Dose 50mg/kg/dose very 12 hours in <7 days of age 50mg/kg/dose every 8 hours in >7 to 20 days of age 50mg/kg/dose every 6 hours in >21 days of age For further information see Y&H ODN formulary - Scroll to top Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function-consider dose reduction in severe renal failure.Consider 25mg/kg every 12 hours. Further Info Cephalosporins are not active against enterococci, listeria, campylobacter or clostridia Supply Available as stock from pharmacy
05.01.02.01	Cefradine
05.01.02.01	Ceftaroline Zinforo^®
24.01	CefTAZidime	Indication Infections due to sensitive Gram-positive and Gram-negative bacteria Dose 50 mg/kg every 24 hours <7 days of age 50 mg/kg every 12 hours 7 to 21 days of age 50 mg/kg every 8 hours >21 days of age Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function Further Info If reduced renal fucntion extend dosage interval - see resources above for further information. Cephalosporins are not active against enterococci, listeria, campylobacter or clostridia Supply: Held as stock on NNU
05.01.02.01	Ceftazidime with avibactam	For intiation by microbiology or infecious diseases team only
05.01.02.01	Ceftriaxone
05.01.02.01	Cefuroxime
11.03.01	Cefuroxime	Unlicensed - prepared by aseptic unit
13.05.03	Certolizumab Cimzia	As per NICE guidelines: TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs TA574: Certolizumab pegol for treating moderate to severe plaque psoriasis
10.01.03	Certolizumab Pegol Cimzia^®	For use in line with NICE guidance
12.01.03	Cerumol^®	Ear drops (Chlorobutanol 5%, Pardichlorobenzene 2%, Arachis (peanut) oil 57.3%) Contains peanut oil
03.04.01	Cetirizine	Tablet 10mg, Liquid 1mg/ml
13.02.01	Cetraben^®	Cream and Bath oil
13.02.01.01	Cetraben^®Bath additive	Bath additive
13.11.03	Cetrimide
08.01.05	Cetuximab Erbitux^®	Available Via CDF KRAS testing to be carried out before initiation. Test also funded by the CDF For use in line with NICE TAs 145, 242 and 439 Patient Access Scheme available for this treatment (in line with NICE TA439)
04.01.01	Chloral Hydrate	Tablets, cloral betaine 707 mg (≡ chloral hydrate 414 mg), Liquid chloral hydrate 143.3 mg/5 mL Alternative for insomnia Usual dose range 1-2 tablets at night or 15-45mls Liquid Max daily dose 5 tablets or 70ml liquid Max single dose 5 tablets or 70ml liquid
24.01	Chloral Hydrate	Indication Short term sedation Dose 10-30 mg/kg/dose every 8 hours reduce dose in mild to moderate hepatic impairment Administration Oral/Enteral liquid Monitoring LFT and U&E Further Info Prescribe as when required if on initiation. May accumulate with repeated doses. Avoid in severe renal and hepatic impariment Supply Available from pharmacy on a named pateint request
08.01.01	Chlorambucil
05.01.07	Chloramphenicol	Ear and eye only
11.03.01	Chloramphenicol	Eye drops 0.5%, Eye ointment 1%, Minims 0.5% (preservative free) Unlicensed use - topically to wound sutures and for bites
12.01.01	Chloramphenicol	Ear drops 5% and 10%
04.01.02	Chlordiazepoxide	Capsules 5mg and 10mg
12.03.04	Chlorhexidine Gluconate Corsodyl^®
13.11.02	Chlorhexidine gluconate 4% Hibiscrub^®	Skin antisepsis MRSA suppression: use once daily for duration of admission
12.03.02	Chlorhexidine Mouthwash
10.01.03	Chloroquine	Tablet,Syrup.
02.02.01	Chlorothiazide	Tablets Not stocked at BTHFT Suspension for paediatric use 250mg/5ml
24.01	Chlorothiazide	Indication Heart failure, hyperinsulinaemic hypoglycaemia and chronic lung disease. Dose 10 mg/kg every 12 hours. Administration Oral - liquid available Monitoring U&E Renal function Further Info May cause hypokalaemia and hyperuricaemia. Doses may vary from 5-20mg/kg depending on indication and specialist advice. Supply Available from pharmacy as a named patient request.
03.04.01	Chlorphenamine	Tablets 4mg. Liquid 2mg/5ml, Injection can cause drowsiness
04.02.01	Chlorpromazine	Tablet 25mg, 50mg, 100mg Oral solution 25 mg/5 mL First generation antipsychotic Usual dose range: 75-300mg in divided doses Max daily dose: 1000mg Max single dose: not stated
24.01	Chlorpromazine	Indication Neonatal abstinence syndrome Dose 1mg/kg every 8 hours. Administration Oral - liquid available Monitoring Blood pressure Further Info Dose can be doubled in severe withdrawal. Maximum dose 6mg/kg/day Supply Available from pharmacy as a named patient.
04.06	Chlorpromazine Hydrochloride
12.03.01	Choline Salicylate Bonjela^® Adult	For use in adults and children over 16
06.05.01	Chorionic Gonadotrophin Pregnyl^®	Injection 5000 unit ampoule
03.02	Ciclesonide Alvesco^®	Aerosol Inhaler 80mcg/dose stocked at BTHFT
01.05.03	Ciclosporin	Injection 50mg/ml, capsules 10mg. 25mg and 50mg, liquid 100mg/ml- secondary care only Ciclosporin must be prescribed by brand - Neoral stocked at BTHFT
08.02.02	Ciclosporin Capimune^®, Neoral^®
08.02.02	Ciclosporin
10.01.03	Ciclosporin
11.99.99.99	Ciclosporin	Eye drops 0.05% Unlicensed
13.05.03	Ciclosporin Capimune	Prescribed by brand SWYAPC shared care guidelines
11.99.99.99	Ciclosporin 0.1% eye drops Verkazia^®	0.3ml unit dose eye drops Paediatric opthalmology use only
11.99.99.99	Ciclosporin 0.1% eye drops Ikervis^®	0.3ml unit dose eye drops Adult opthalmology use only
09.05.01.02	Cinacalcet	Tablets 30mg, 60mg and 90mg
04.06	Cinnarizine	Tablets 15mg
05.01.12	Ciprofloxacin
11.03.01	Ciprofloxacin	Eye drops 0.3%
12.01.01	Ciprofloxacin
20	Cisapride	FORM AND STRENGTH: Tablets 10mg INDICATION: Prokinetic DOSE: 10mg three to four times daily PACK SIZE: SUPPLIER: LICENSE TYPE: PRESCRIBING CONSULTANT: DATE AUTHORISED:
08.01.05	Cisplatin
04.03.03	Citalopram	Tablets 10mg, 20mg and 40mg Oral drops 40mg/ml, 4 drops (8mg) equivalent to 10mg tablet Usual dose range 20-40mg daily Max daily dose 40mg Max single dose 40mg
01.06.04	Citrate micro enema	Micro-enema
08.01.03	Cladribine Litak^®
08.01.03	Cladribine
05.01.05	Clarithromycin
05.01.06	Clindamycin
07.02.02	Clindamycin Dalacin^®	Cream 2%, 40g pack with 7 applicators
13.06.01	Clindamycin 1% Dalacin T^®	Lotion
04.08.01	Clobazam
13.04	Clobetasol Propionate (with antimicrobials) Dermovate-NN^®	Ointment, Cream Very Potent with antimicrobial Now available generically but more expensive than before approx £64.00
13.04	Clobetasol Propionate 0.05% Dermovate^®	Cream, Ointment, Scalp application, Shampoo (Etrivex®) Very potent Prescribe by brand name (hospital only)to avoid confusion between similar sounding generic names
13.04	Clobetasone Butyrate 0.05% Eumovate^®	Cream, Ointment Moderately potent Prescribe by brand name (hospital only)to avoid confusion between similar sounding generic names
13.04	Clobetasone butyrate 0.05%, oxytetracycline 3%, nystatin 100,000units/g Trimovate^®	Ongoing supply problem Cream Contains:Clobetasone Butyrate 0.05%, Oxytetracycline 3%, Nystatin 100,000 units/g Moderately potent with antimicrobials
08.01.03	Clofarabine Evoltra^®	VIA CDF for following Acute lymphoblastic leukaemia in patients with relapsed/ refractory disease in whom the intent is to use treatment as a bridge to bone marrow transplantation Acute Myeloblastic leukaemia in patients with relapsed/ refractory disease in whom the intent is to use treatment as a bridge to bone marrow transplantation
04.01.01	Clomethiazole Heminevrin^®	Cspsules 192mg clomethiazole base alternative for insomnia Usual dose range: 1-2 capules at night Max daily dose 2 capsules Max single dose 2 capsules
06.05.01	Clomifene Citrate	Tablets 50mg
04.03.01	Clomipramine	Capsules 10mg, 25mg, 50mg, 100mg Tablets m/r 75mg Usual dose range 30-150mg in divided doses Max daily dose 250mg Max single dose 250mg
04.02.03	Clonazepam
04.08.01	Clonazepam
04.08.02	Clonazepam	Injection 1mg/ml Management of disturbed befaviour Max daily dose 500mcg to 2mg (6mg in 24 hours) max single dose 2mg
24.01	Clonazepam	Indication Continuous severe seizures resisant to routine anticonvulsants. Dose 100 micorgram/kg every 24 hours. slow IV bolus IV infusion, initially bolus dose as above, followed by a continuous infusion starting at 10 microgram/kg/hour. Adjust according to response, up to 60microgram/kg/hr has been used. Administration Slow IV injecition over 2-3minutes Continuious infusion if recommended by specialist. Adsorbed on PVC. If PVC apparatus used complete infusion within 2 hours IV or PO See Medusa IV guide for information on administration - Scroll to top Monitoring Respiration Salivary and bronchial hypersecretion. Further Info Prolonged infusion may lead to accumulaiton and delay recovery Can be reversed by flumazenil. IV injection, 10microgram/kg repeat at 1 minute intervals to a maximum of 40microgram/kg(2mg). If necessary this may be followed by an infusion of 2-10microgram/kg/hour. Supply Available from pharmacy as a stock item
02.05.02	Clonidine Hydrochloride
02.09	Clopidogrel	Tablet If needed tablets can be dispersed in water.
07.02.02	Clotrimazole	Cream 1%, Pessaries 500mg, 200mg and 100mg 2% cream not stocked at BTHFT, 1% cream as effective for relief of external thrush symptoms
12.01.01	Clotrimazole Canesten^®	Solution 1%
13.10.02	Clotrimazole
04.02.01	Clozapine Clozaril^®	HOSPITAL ONLY To be initiated by consultant psychiatrist only. For treatment-resistant schizophrenia Tablets 25mg and 100mg Usual dose range: Adjustable initial titration (CPMS blood tests) 200-450mg Max daily dose: Max 900mg
04.02.01	Clozapine Denzapine^®	CLOZARIL brand used within BTHFT
04.02.01	Clozapine Zaponex^®	CLOZARIL brand used within BTHFT
13.09	Coal Tar Extract 5% (Alcoholic) Alphosyl 2 in 1^®
13.05.02	Coal Tar in Lassars Paste	2%, 4% & 5%
13.05.02	Coal tar lotion 5% Exorex^®	Lotion
02.02.04	Co-amilofruse (furosemide and amiloride)	Tablets If needed tablets can be dispersed in water
05.01.01.03	Co-Amoxiclav
05.01.01.03	Co-Amoxiclav Augmentin^®
04.09.01	Co-Beneldopa Madopar^®CR
04.09.01	Co-Beneldopa Madopar^®
11.07	Cocaine	specialist use only 4% eye drops
04.09.01	Co-Careldopa Sinemet^® CR
04.09.01	Co-Careldopa Sinemet^®
04.09.01	Co-Careldopa Half Sinemet ^®CR
04.09.01	Co-Careldopa and Entacapone Stalevo^®
13.06.02	Co-Cyprindiol 2000/35 (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms) Dianette^®
01.06.02	Co-danthramer	Capsule 25/200mg, Suspension 25/200mg/5ml Generally restricted for use in terminally ill patients can colour the urine red
01.06.02	Co-danthrusate
01.04.02	Codeine	Tablets 15mg, 30mg, 60mg and syrup (25mg/5ml)
04.07.02	Codeine analgesia	Tablet, Syrup (25mg/5mL), Injection (not recommended as no advantages over morphine and is a CD)
10.01.04	Colchicine
09.06.04	Colecalciferol	Colecalciferol preparations supplied for treatment of deficency only Plenchol 20,000 unit capsules Thorens 10,000 unit/ml oral drops- for children and adults with swallowing difficulties Maintenance doses (e.g. 1000 unit capsules) not stocked
02.12	Colesevelam
01.09.02	Colestyramine	Powder sachets
02.12	Colestyramine	Questran^® Questran Light^®- sugar free
05.01.07	Colistimethate Promixin^®	Nebulules. Nebuliser solution for use with I-neb nebuliser Work on repatriation of these treatments to secondary care is under discussion with NHS England. Until this work is concluded, GPs should continue to supply under shared care arrangements
05.01.07	Colistimethate for nebulisation Colomycin^®
10.03.01	Collagenase Xiapex^®
06.04.01.01	Combined continuous HRT tablet Premique ^®	Premique® low dose tablet
06.04.01.01	Combined cyclical HRT tablet Elleste-Duet®, Prempak-C^®
07.03.01	Combined Hormonal Contraceptives Evra	Patches - Ethinylestradiol with Norelgestronim One patch to be applied weekly for 3 weeks followed by a 7 day patch-free interval
07.03.01	Combined Hormonal Contraceptives TriNovum^®
09.02.02.01	Compound Sodium Lactate Intravenous Infusion	Hartmann's Solution 500ml or 1 litre Half Strength Hartmann's Solution Dextrose 5% & Half Strength Hartmann's Solution 500ml polyfusor Hartmann's Solution = Sodium Chloride 0.6%, Sodium Lactate 0.25%, Potassium Chloride 0.04%, Calcium Chloride 0.027%
01.04.02	Co-Phenotrope Lomotil^®	Tablet contains diphenoxylate 2.5mg and atropine 25 microgrames
05.01.08	Co-trimoxazole
08.01.05	Crisantaspase Erwinase^®
08.01.05	Crizotinib Xalkori^®
13.03	Crotamiton Eurax^®
04.06	Cyclizine	Tablets 50mg
11.05	Cyclopentolate Hydrochloride	Mydrilate^® 0.5% and 1% eye drops Minims^® Cyclopentolate Hydrochloride 0.5% and 1% single use eye drops
08.01.01	Cyclophosphamide
06.04.02	Cyproterone Acetate	Tablet 50mg
08.03.04.02	Cyproterone Acetate
08.01.03	Cytarabine DepoCyte^®
08.01.03	Cytarabine
02.08.02	Dabigatran	Capsules 75mg, 110mg and 150mg Rivaroxaban is the oral anticoagulant of choice for prophylaxis of VTE following total knee and hip replacement POSITION STATEMENT TO ADD IN REGARDS TO ROLE IN STROKE AND AF
08.01.05	Dacarbazine
08.02.02	Daclizumab Zenapax^®
08.01.02	Dactinomycin Cosmegen Lyovac^®
24.01	Dalivit	0.6mls once daily
02.08.01	Danaparoid	Injection 1250units/ml Can be used as an alternative in patients who have developed heparin-induced thrombocytopenia (HIT)
06.07.02	Danazol	Capsules 100mg, 200mg
10.02.02	Dantrolene
15.01.08	Dantrolene Sodium
09.01.03	Darbepoetin Alfa	Injection: - Prefilled syringes - Prefilled disposable injection device (Aranesp®SureClick)
07.04.02	Darifenacin Emselex^®	Tablet 7.5mg and 15mg
05.03.01	Darunavir Prezista^®
08.01.05	Dasatinib Sprycel^®
08.01.02	Daunorubicin
09.01.03	Deferasirox	Dispersible tablet
09.01.03	Deferiprone	Tablet
06.03.02	Deflazacort Calcort^®	Tablet 6mg
08.03.04.02	Degarelix Firmagon^®
06.06.02	Denosumab Prolia^®	Shared care guideline available at - denosumab in primary care guideline If the patient and healthcare professional opt for home administration as mentioned in the shared care guidance, the patient can be enrolled in the Prolong patient support programme. Prolong contact details: Prolong.support@nhs.net / 0330 808 8686. you in the Prolong patient support programme
06.06.02	Denosumab XGEVA^®	See denosumab (Prolia^®) for drug saftey information
13.08.02	Dermacolor^®
13.02.01	Dermol^®
18	Desferrioxamine
09.01.03	Desferrioxamine Mesilate
15.01.02	Desflurane Suprane^®
24.02	Designer Fluids	See Link
03.04.01	Desloratadine Neoclarityn^®	Tablets 5mg
06.05.02	Desmopressin Noqdirna^®	Sodium should be monitored at 7 days and 1 month after starting
06.05.02	Desmopressin	DDAVP: Tablet, Nasal spray, Sublingual tablet , Injection 4mcg/ml. Indicated for diabetes insipidus or polyuria/polydypsia. Usually tds. Water Deprivation test single dose - see protocol below Desmotabs: Indicated for primary nocturnal enuresis. Usually once daily. Octim: Injection 15mcg/ml - For bleeding episodes in responding patients with mild haemophilia A, Von Willebrands Disease and platelet function disorders. (Nasal spray Non-Formulary)
06.03.02	Dexamethasone	Tablets 0.5mg, 2mg, oral solution 2mg/5ml Dexamethasone 2mg/5ml liquid is used for 500mcg and 1mg doses of dexamethasone Dexamethasone 2mg Tablets are used for doses 2mg and above
24.01	Dexamethasone BASE	Indication Ventilator dependent chronic lung disease(CLD) Dose Prescribe and dose as Dexamethasone BASE Individualised dosing after discussion with consultant. Doses have ranged from 50micrograms/kg/ alternate days to 500micrograms/kg/day in divided doses. See Neonatal Formulary for further information if required Administration IV or PO See Medusa IV guide for information on administration - Scroll to top Monitoring Blood sugars, Blood pressure, Renal function, Liver function, GI side effects Further Info IV may be diluted in sodium chloride 0.9% or glucose 5% to aid administration Supply Available from pharmacy as a stock item
11.04.01	Dexamethasone eye drops	Eye drops 0.1% and single dose minims 0.1%
11.04.01	Dexamethasone intravitreal implant Ozurdex^®
12.01.01	Dexamethasone with Antibacterial Otomize^®	Ear spray (Dexamethasone 0.1%, Neomycin Sulphate 3250 units per mL and Glacial Acetic Acid 2%)
12.01.01	Dexamethasone with Antibacterial Sofradex^®	Drops (Dexamethasone 0.05%, Framycetin Sulphate 0.5%, Gramicidin 0.005%) Treatment of otitis externa
11.04.01	Dexamethasone with Antibacterials Sofradex^®	Drops (ear or eye) Dexamethasone (as sodium metasulphobenzoate) 0.05% Framycetin sulfate 0.5% Gramicidin 0.005%
11.04.01	Dexamethasone with Neomycin and Polymyxin B sulphate Maxitrol^®	Eye drops, Eye ointment Generally prescribed post surgery
04.04	Dexamfetamine	Tablets 5mg Drug treatment of Attention Deficit Hyperactivity Disorder (ADHD) Usual dose range 2.5mg - 5mg TDS (1mg/kg) max daily dose 20mg max single dose 5mg
15.01.04.04	Dexmedetomidine
04.07.02	Diamorphine	Injection
04.01.02	Diazepam	Tablets 2mg, 5mg and 10mg. Oral suspension 2mg/5ml Usual dose range: 2-10mg three times daily Max daily dose 30mg Max single dose 10mg
04.08.02	Diazepam
10.02.02	Diazepam	Tablets 2mg, 5mg, 10mg Liquid 2mg/5ml
15.01.04.01	Diazepam
24.01	Diazepam	Indication Sedation and Seizures Dose 200mg/kg/dose repeated after 10 minutes if necessary. Administration Slow IV bolus if given IV IV can be given orally or rectally See Medusa IV guide for information on administration - Scroll to top Monitoring hypotension, apnoea, respiratory depression, urinary retention,gastro-intestinal disturbances Further Info: Use Diazemuls band only for IV injection, less irritant than other brands. Can be reversed by flumazenil. IV injection, 10microgram/kg repeat at 1 minute intervals to a maximum of 40microgram/kg(2mg). If necessary this may be followed by an infusion of 2-10microgram/kg/hour. Supply: Available from pharmacy as a stock item
06.01.04	Diazoxide Eudemine^®	For specialist use only
10.01.01	Diclofenac	Following Drug Safety Updates the use of diclofenac is restricted to use where the risks and benefits of continued treatment have been considered (see MHRA Drug Safety Updates below) Suppositories available: 12.5mg, 25mg, 50mg, 100mg
11.08.02	Diclofenac Voltarol^® Ophtha
13.08.01	Diclofenac Solaraze^®
11.08.02	Diclofenac Sodium Voltarol^® Ophtha multidose
18	Dicobalt edetate
01.02	Dicycloverine	Tablets 10mg and 20mg, Liquid 10mg/5ml
08.03.01	Diethylstilbestrol
02.01.01	Digoxin	Tablets 62.5mcg, 125mcg and 250mcg, Elixir 50mcg/ml, Injection 250mcg/ml (secondary care only) Bioavailability’s are approximately: Injection 100%, Liquid 80%, Tablets 70%
24.01	Digoxin	REVIEW? Indication: Supraventricular tachycardia Dose: Total loading dose given as ½ immediately ¼ at 8 hours ¼ at 16 hours >2.5kg total loading dose: IV = 35 micrograms/kg oral = 45 micrograms/kg >2.5kg oral maintenance dose: 10 micrograms/kg od For low birth weight babies see Neonatal Formulary Administration IV or Oral Monitoring Potassium, renal function, arrhythmias, conduction disturbances, thrombocytopenia. The plasma-digoxin concentration should be maintained in the range 0.8–2 micrograms/litre. Blood should be taken at least 6 hours after a dose Further Info: Hypokalaemia predisposes the child to digitalis toxicity. Supply: Available from pharmacy as a named pateint. Liquid suppled as 50micrograms in 5mls (10micrograms/ml) Always check dose carefully because an overdose can cause death.
02.01.01	Digoxin specific antibody fragments Digifab^®	DigiFab® replaces Digibind® (Dec 2011). Click here for Digifab SPC Very rarely needed and extremely expensive. Discuss with the National Poisons Centre (08448920111) first, then with Medicines Information (4598) or the on call pharmacist (via switchboard after 17:30). Toxbase website here
04.07.02	Dihydrocodeine	Tablet, Tablet MR, Oral solution, injection Injection is a CD
02.06.02	Diltiazem	Tablets, Capsules Prescribe by brand according to medicines policy
01.07.04	Diltiazem Cream 2%	Unlicensed - available for patients unresponsive or intolerant to GTN ointment Dose 2cm twice daily, store in fridge , 1 tube lasts one month
13.05.03	Dimethyl fumarate Skilarence	As per NICE guidelines: TA475: Dimethyl fumarate for treating moderate to severe plaque psoriasis
13.10.04	Dimeticone Hedrin^®
07.01.01	Dinoprostone Propess^®	Pessaries releasing 10mg over 24 hours
07.01.01	Dinoprostone Prostin E2^®	IV solution 1mg/ml Injection Vaginal tablet (Prostin E2)
13.02.01	Diprobase^®	Cream, Ointment
02.09	Dipyridamole	Capsule MR Secondary prevention of ischaemic stroke and TIA normally in combination with aspirin for existing patients and those unable to take clopidogrel If needed capsules can be opened and beads mixed with water (do not crush). Flush enteral tubes well as there is potential for blockage.
11.99.99.99	Disodium Edetate 0.37%	Solution 20mL (preservative free) (Unlicensed Product)
20	Disodium Edetate 0.37% eye drops EDTA	Solution 20ml (preservative free) (Unlicensed Product) Specialist use only Unlicensed request signed by Helen Devonport on behalf of Nigel James 11/06/2014 Treatment of Calcific Band Keratopathy
06.06.02	Disodium Pamidronate	injection
02.03.02	Disopyramide	Capsule, Tablet MR, Injection (secondary care only)
13.05.02	Dithranol Dithrocream^®	Cream 0.1% Cream 0.25% Cream 0.5% Cream 1% Cream 2%
13.05.02	Dithranol Ointment BP
13.05.02	Dithranol Paste BP
02.07.01	Dobutamine	Infusion (secondary care only)
24.01	DoBUTamine	Indication Hypotension Dose 5-20 micrograms/kg/min as continious infusion. For further information see Y&H ODN formulary - Scroll to top Administration See Medusa IV guide for ADDITIONAL information on administration - Scroll to top USE GUARDRAILS ON INFUSION PUMP Syringe concentrations 60mg in 50mL (1200micogram/mL) SINGLE STRENGTH 120mg in 50mL (2400micogram/mL) - DOUBLE STRENGTH Monitoring Blood pressure(marked increase in systolic blood pressure indicates overdose) arrhythmias,dyspnoea, bronchospasm and hypokalaemia Further Info Compatibility information can be found on Medusa Solutions of dobutamine may turn pink due to a slight oxidation of the drug. Such solutions are safe to use and there is no significant loss of potency. Supply: Available from pharmacy as a standard stock
08.01.05	Docetaxel Taxotere^®
01.06.02	Docusate Sodium	Capsule 100mg, Solution 50mg/5ml (adult) 12.5mg/5ml (paediatric)
04.06	Domperidone	Tablet, Suspension, Suppository See link below for MHRA advice about dose restrictions and contraindications
04.11	Donepezil	Tablet 5mg, 10mg First Line for Mild to moderate Alzheimers disease usual dose range 5-10mg at night max daily dose 10mg at night Max single dose 10mg
02.07.01	Dopamine	Infusion (secondary care only)
24.01	DOPamine	Indication Hypotension Dose 5-20 micrograms/kg/min as continious infusion. For further information see Y&H ODN formulary - Scroll to top Administration See Medusa IV guide for ADDITIONAL information on administration - Scroll to top USE GUARDRAILS ON INFUSION PUMP Syringe concentrations 60mg in 50mL (1200micogram/mL) SINGLE STRENGTH 120mg in 50mL (2400micogram/mL) - DOUBLE STRENGTH Monitoring Blood pressure(marked increase in systolic blood pressure indicates overdose) arrhythmias,dyspnoea, bronchospasm and hypokalaemia Further Info Compatibility information can be found on Medusa Supply Available from pharmacy as a standard stock
02.07.01	Dopexamine	Infusion (secondary care only)
03.07	Dornase Alfa Pulmozyme^®	Nebuliser Solution 2.5ml (pack size 30) Expensive item, store in the fridge Work on repatriation of these treatments to secondary care is under discussion with NHS England. Until this work is concluded, GPs should continue to supply under shared care arrangements
11.06	Dorzolomide	Eye drops 2%
11.06	Dorzolomide 2% with Timolol 0.5% Cosopt^®	Eye drops
04.03.01	Dosulepin	Tablets 75mg Capsules 25mg Usual dose range 75-225mg Max daily dose 225mg Max single dose 225mg in one to three divided doses
13.02.01	DoubleBase^®	Doublebase gel Dayleve gel (can be used less often than doublebase original, twice daily) Shower gel
03.05.01	Doxapram Dopram^®	Injection
15.01.07	Doxapram Dopram^®
02.05.04	Doxazosin	Tablet, Tablet MR May be used as a 4th line option in the management of hypertension when control has not been achieved with other agents.
07.04.01	Doxazosin
04.03.01	Doxepin
13.03	Doxepin Hydrochloride Xepin^®
08.01.02	Doxorubicin Hydrochloride
08.01.02	Doxorubicin Hydrochloride Caelyx^®
05.01.03	Doxycycline
05.04.01	Doxycycline
02.03.02	Dronedarone Multaq^®	Tablets Restricted for cardiologist initiation in accordance with NICE guidance (TA197).
04.06	Droperidol Xomolix^®	For use by ICU and theatres only
03.01.05	Drug Delivery Device Haleraid^®	For use with MDI pressurised inhalers to aid when strength in hands is impaired (eg in arthritis)
03.01.05	Drug Delivery Device Volumatic^®	Large volume device for adults and children available with a paediatric mask
03.01.05	Drug Delivery Device AeroChamber Plus^®	Adult and children > 5 years = Blue (+/- mask) Child 2-5 years = Yellow Infant (6 months - 2 years) = Orange
03.01.05	Drug Delivery Device Babyhaler^®	for paediatric use
06.01.02.03	Dulaglutide Trulicity^®	0.75mg/0.5ml & 1.5mg/0.5ml pre-filled pen/pre-filled syringe Restricted for initiation by diabetes team
04.03.04	Duloxetine Cymbalta^®	Capsules 30mg and 60mg Usual dose range 60mg daily Max daily dose 60mg Max single dose 60mg
04.03.04	Duloxetine Yentreve^®
04.03.04	Duloxetine Cymbalta^®	Capsules 30mg and 60mg Usual dose range 30-60mg daily Max daily dose 120mg Max single dose 120mg
07.04.02	Duloxetine Yentreve^®	Capsule 20mg and 40mg
13.08.01	Dundee reflective sun creams Dundee Block^®
13.05.03	Dupilumab Dupixent^®	To be used accordingly to NICE guidelines: TA534: Dupilumab for treating moderate to severe atopic dermatitis
06.04.02	Dutasteride Avodart^®	Capsule 500micrograms
06.04.01.02	Dydrogesterone Duphaston^®
13.02.01	E45^®	Cream, Lotion, Wash emmolient
10.02.01	Edrophonium Chloride
09.01.04	Eltrombopag	Tablet
11.04.02	Emedastine Emadine^®	Eye drops 0.05%
13.02.01.01	Emollient Bath Additive Aveeno^®	Bath oil
13.02.01.01	Emollient Bath Additive Oilatum^®	Bath additive
13.02.01.01	Emollient Bath Additive with Anitmicrobials Dermol^®
13.02.01	Emollient preparation Dermamist^®
06.01.02.03	Empagliflozin Jardiance^®	Restricted for initiation by diabetes team Replaced use of canagliflozin and dapagliflozin
13.02.01	Emulsifying Ointment BP	Ointment
02.05.05.01	Enalapril	Tablet If needed tablets can be crushed and dispersed in water
08.01.05	Encorafenib Braftovi^®
08.01.05	Encorafenib Braftovi^®
05.03.01	Enfuvirtide Fuzeon^®
02.01.02	Enoximone	Injection 5mg/ml 20ml amp Secondary care use only Plastic apparatus should be used, crystal formation if glass used
04.09.01	Entacapone Comtess^®
05.03.03	Entecavir Baraclude^®	Initiation by specialist consult only
02.07.02	Ephedrine	Injection (secondary care only)
12.02.02	Ephedrine	Nasal drops 0.5% Nasal drops 1%
08.01.02	Epirubicin hydrochloride
02.02.03	Eplerenone	Cardiology use only Tablet 25mg and 50mg Second line agent if spironolactone is not tolerated for use within the licensed indication of stable post MI patients with left ventricular dysfunction and clinical evidence of heart failure in line with NICE guidance. Second line aldosterone antagonist if spironolactone is not tolerated for NYHA class II heart failure.
09.01.03	Epoetin alfa Eprex^®	Injection Restricted for haematology and renal use only
09.01.03	Epoetin beta NeoRecormon^®	Injection Restricted for haematology and renal use only
02.08.01	Epoprostenol
02.09	Eptifibatide
04.07.04.02	Erenumab	For prophylaxis of migraine For initiation by neurology only as per PAS scheme NICE TA in development - only to be initiated by neurology team
09.06.04	Ergocalciferol
07.01.01	Ergometrine Maleate	Injection 500 micrograms/ml
07.01.01	Ergometrine Maleate and Oxytocin Syntometrine^®	Injection ergometerine 500 micrograms and oxytocin 5units/ml
08.01.05	Eribulin Halaven^®	Available via CDF if the following criteria met Treatment of patients with locally advanced or metastatic breast cancer who have been previously treated with (or unsuitable for) an anthracycline, a taxane and capecitabine
08.01.05	Erlotinib Tarceva^®
08.01.05	Erlotinib Tarceva^®
05.01.02.02	Ertapenem Invanz^®
05.01.05	Erythromycin
24.01	Erythromycin	Indication Gastric reflux Infection Dose 12.5 mg/kg every six hours IV or Oral 3mg/kg every six hours for gastro-intestinal stasis - oral only Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function, LFT, Long term use for reflux may cause pyloric stenosis Further Info 2/52 course for confirmed chlamydia Supply Available from pharmacy as named patient. Oral liquid kept as stock.
04.03.03	Escitalopram	Tablets 5mg, 10mg, 20mg Short term management of Generalised Anxiety Disorder Usual dose range 10-20mg Max daily dose 20mg Max single dose 20mg
02.04	Esmolol	Injection (secondary care only)
01.03.05	Esomeprazole
10.01.03	Etanercept Enbrel^®	Subcut injection 25mg and 50mg On recommendation from specialist consultant
13.05.03	Etanercept Benepali	Benepali is brand of choice at BTFHT, Enbrel should only be prescribed if there has been prior approval from DTC. Available as a SC injection - pen/syringes Prescribe as per NICE guidelines psoriasis/psoriatic arthritis: TA103: Etanercept and efalizumab for the treatment of adults with psoriasis TA199: Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
05.01.09	Ethambutol
07.03.01	Ethinylestradiol / levonorgestrel phased pill TriRegol^®, Logynon^®, Logynon^®ED	TriRegol^®, Logynon^® Phasic standard strength (21 day preparation) Logynon^®ED Phasic standard strength (28 day preparation) Prescribe by brand, TriRegol preferred brand at BTHFT
07.03.01	Ethinylestradiol 20 mcg / norethisterone 1mg Loestrin 20^®	Monophasic standard strength (21 day preparation)
07.03.01	Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel^®, Mercilon^®	Monophasic low strength (21 day preparation) Prescribe by brand, Gedarel preferred brand at BTHFT
07.03.01	Ethinylestradiol 20mcg / gestodene 75 mcg Millinette^®20/75, Femodette^®	Monophasic low strength (21 day preparations)
07.03.01	Ethinylestradiol 30 mcg / drospirenone 3 mg Yasmin^®,Acondro^®	Monophasic Combined oral contraceptive (21 day preparation) Prescribe by brand, Acondro preferred brand at BTHFT
07.03.01	Ethinylestradiol 30mcg / desogestrel 150mcg Gedarel^®
07.03.01	Ethinylestradiol 30mcg / gestodene 75 mcg Millinette^®, Femodene^®, Femodene^®ED	Millinette^®, Femodene^® Monophasic standard strength (21 day preparation) Femodene^®ED Monophasic standard strength (28 day preparation) Prescribe by brand, Millinette preferred brand at BTHFT
07.03.01	Ethinylestradiol 30mcg / levonorgestrel 150mcg Rigevidon^®, Microgynon 30^® preps, Levest^®, Ovranette^®	Rigevidon^®, Microgynon 30^®, Levest^®, Ovranette^® Monophasic standard strength (21 day preparation) Microgynon 30 ED^® Monophasic standard strength (28 day preparation) Prescribe by brand, Levest preferred brand at BTHFT
07.03.01	Ethinylestradiol 35 mcg / noresthisterone 500mcg Ovysmen^®, Brevinor^®	Monophasic standard strength (21 day preparation)
07.03.01	Ethinylestradiol 35 mcg / norgestimate 250 mcg Cilest^®
04.08.01	Ethosuximide
15.01.01	Etomidate Etomidate-Lipuro^®
15.01.01	Etomidate Hypnomidate^®
07.03.02.02	Etonorgestrel Nexplanon^®	Implant (subdermal) 68mg
08.01.04	Etoposide Etopophos^®
08.01.04	Etoposide
10.01.01	Etoricoxib Arcoxia^®
05.03.01	Etravirine Intelence^®
08.01.05	Everolimus Afinitor^®	Available VIA CDF
02.12	Evolocumab Repatha^®	For use in line with NICE TA394
08.03.04.01	Exemestane
10.01.04	Febuxostat
02.12	Fenofibrate	Micro Capsule Supralip 160mg is equivalent to 200mg of the other micronised brands.
04.07.02	Fentanyl Actiq^®	Lozenges 200, 400 and 600 mcicrograms
04.07.02	Fentanyl	Patch For patients with swallowing difficulties on stable doses of opiates or on pain team specialist advice when morphine isn't suitable. For chronic non-cancer pain, doses greater than 50 micrograms / hour by specialist recommendation or advice only.
15.01.04.03	Fentanyl
24.01	Fentanyl	Indication Sedation for intubation Dose 3 micrograms/kg/dose Administration Take 1.0mL (50micrograms) of fentanyl and add to 4.0mL of sodium chloride 0.9%. Giving a concentration of 10micrograms in 1mL See Medusa IV guide for information on administration - Scroll to top Monitoring Blood pressure, muscle rigidity and respiratory rate Further Info: See Preparation of drugs for intubation Supply: Available from pharmacy as a stock item IV as 50micrograms in 1ml Controlled drug.
09.01.01.02	Ferric Carboxymaltose Ferinject^®	Ferinject should only be prescribed in the following clinical areas: Renal Obstetrics and gynaecology Paediatrics A single dose of Ferinject should not exceed 1,000 mg of iron (20 mL) per day. Do not administer 1,000 mg of iron (20 mL) more than once a week. For dose calculation please SPC
09.01.01.02	Ferric Derisomaltose Monofer^®	Monofer should be prescribed as the IV iron of choice at BTHFT. Monofer should be prescribed in all clinical areas with an exception of renal, paediatrics, obstetrics and gynaecology. The guideline can be found here.
09.01.01.01	Ferrous Fumarate Fersamal^®
09.01.01.01	Ferrous Gluconate	Tablet 300mg 300mg tablet = 35mg of iron. Only use if intolerent of other iron salts (but often no better)
09.01.01.01	Ferrous Sulphate	Tablet 200mg 200mg tablets= 65mg iron
07.04.02	Fesoterodine Toviaz^®	Tablet 4mg and 8mg
06.01.01.01	Fiasp^® Insulin Aspart	Rapid acting recombinant human insulin analogue 10ml vial 3ml cartridge 3ml prefilled pen Restricted for initiation by diabetes team For patients who require more rapid onset of action of insulin than provided by other rapid acting insulins
05.01.07	Fidaxomicin Dificlir^®
09.01.06	Filgrastim Zarzio^®
06.04.02	Finasteride	Tablet 5mg
08.02.04	Fingolimod
02.03.02	Flecainide	Tablet, Injection (secondary care only)
01.06.05	Fleet Phospho-soda^®	oral solution
13.04	Flucinolone Acetonide 0.025% Synalar^®	Cream, Ointment Potent
05.01.01.02	Flucloxacillin
24.01	Flucloxacillin	Indication Infection - beta-lactamase-producing staphylococci. Dose 50mg/kg every 12 hours < 7 days of age 50mg/kg every 8 hours 7 - 21 days of age 50mg/kg every 6 hours 21 - 28 days of age IV = PO dose For further information see Y&H ODN formulary - Scroll to top Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal function, liver function Further Info Supply Available from pharmacy as a stock item
05.02	Fluconazole
07.02.02	Fluconazole	Capsule 50 mg and 150mg 150mg STAT dose 50mg daily for 7 days
24.01	Fluconazole	Indication: Systemic Candida infection Dose: Prophylaxis - All babies with central IV access and <1kg 3 mg/kg every 72 hours if less than 14 days of age 3 mg/kg every 48 hours 2-4 weeks of age 3 mg/kg every 24 hours >4 weeks of age Treatment 6-12 mg/kg every 72 hours if less than 14 days of age 6-12 mg/kg every 48 hours 2-4 weeks of age 6-12 mg/kg every 24 hours >4 weeks of age Excreted unchanged in urine so extended dosage interval after first dose if poor renal function. See Evelina formulary For further information see Y&H ODN formulary - Scroll to top See Fungal Infection Guideline Administration See Medusa IV guide for information on administration - Scroll to top Monitoring Renal fucntion, U&E, ECG(QT prolongation) Further Info: IV contains equivalent of 0.46mmol/kg of sodium for 6mg/kg dose. Supply: Available from pharmacy as a stock item
08.01.03	Fludarabine Phosphate Fludara^®
06.03.01	Fludrocortisone Acetate Florinef^®	Tablet 100 microgram If needed tablets can be dispersed in water. Flush well if giving via enteral tube
13.04	Fludroxycortide Haelan^®
15.01.07	Flumazenil Anexate^®
12.01.01	Flumetasone 0.02% with Clioquinol 1% Locorten-Vioform^®	Drops
11.04.01	Fluocinolone intravitreal implant Iluvien®	Opthalmology use only
11.08.02	Fluorescein Sodium Minims^®	Eye drops 1% and 2%
11.04.01	Fluorometholone FML^®	Eye drops 0.1%
08.01.03	Fluorouracil
08.01.03	Fluorouracil
11.99.99.99	Fluorouracil	Intravitreal Injection Unlicensed - prepared by aseptic unit
13.08.01	Fluorouracil Efudix^®
04.03.03	Fluoxetine	Capsules 20mg, 60mg (60mg capsules significantly more expensive, prescribe in multiples of 20mg where possible) Liquid 20mg/5ml Usual dose range 20-60mg daily Max daily dose 60mg Max single dose 60mg
04.02.01	Flupentixol Depixol^®	Tablet 3mg (depixol) Tablets 0.5g and 1mg (fluanxol)
04.03.04	Flupentixol Fluanxol^®	Tablets 0.5mg, 1mg Usual dose range 1-3mg Max daily dose 3mg Max single dose 2mg
04.02.02	Fluphenazine Decanoate	Depot injection
04.02.01	Fluphenazine Hydrochloride Moditen^®	Injection (oily) 25mg/ml and 100mg/ml
08.03.04.02	Flutamide
03.02	Fluticasone Flixotide^®	Aersol inhaler and Dry powder (Accuhaler)
03.02	Fluticasone and formoterol Flutiform^®	Aerosol Inhaler 50mcg/5mg, 125mcg/5mcg and 250mcg/5mcg
03.02	Fluticasone and salmeterol Seretide^®	Evohaler, Accuhaler
12.02.01	Fluticasone furoate Avamys^®	Nasal Spray 27.5 micrograms per spray
03.02	Fluticasone furoate & vilanterol Revlar Ellipta^®
12.02.01	Fluticasone Propionate	Nasal spray 50micrograms per spray
12.02.01	Fluticasone Propionate Flixonase Nasule^®	0.4ml unit dose vials (400 micrograms/unit dose)
03.02	Fluticasone with umeclidinium and vilanterol Trelegy Ellipta^®	Trelegy Ellipta 92/55/22 dry powder inhaler
09.01.02	Folic Acid	Tablet, Syrup Tablets can be crushed and dispersed. Liquid available for paediatrics.
02.08.01	Fondaparinux
03.01.01.01	Formoterol Oxis^®	Long-acting beta-agonist Only Oxis brand (6mcg and 12mcg) stocked at BTHFT Use Oxis inhaler as alternative to Atimos Modulite, but counsel patient as Oxis is a dry powder inhaler
04.06	Fosaprepitant Ivemend^®
04.07.04.02	Fremanezumab Ajovy	To be prescribed by neurology As per NICE TA 631 - Fremanezumab for preventing migraine To be prescribed as per PAS scheme
13.05.02	Fumaderm^®	Awaiting Service agreement with CCG
02.02.02	Furosemide	Tablet 20mg and 40mg, Oral Solution 40mg/5ml, Injection 10mg/ml
24.01	Furosemide	Indication Oedema in heart failure, renal disease and pulmonary oedema Dose PO & IV 0.5–1 mg/kg every 12–24 hours, alternatively 0.5–1 mg/kg every 24 hours, if corrected gestational age under 31 weeks. 0.5–1 mg/kg every 8 hours as needed increased if necessary up to 2 mg/kg every 8 hours. For further information see Y&H ODN formulary - Scroll to top Administration See Medusa IV guide for information on administration - Scroll to top Monitoring U&E, Ca, Blood sugars, urine output Nephrocalcinosis and nephrolithiasis reported with long-term use of furosemide in preterm infants Further Info: IV can be given orally. Caution with liquid preparations and their alcohol content Supply: Available from pharmacy as stock item
11.03.01	Fusidic Acid	Eye drops 1% Alternative to chloramphenicol for empirical treatment in people who: - Are pregnant. - Have a personal or family history of blood dyscrasias, such as aplastic anaemia. - Are intolerant of chloramphenicol. - Need a twice-a-day treatment for infective conjunctivitis
13.10.01.02	Fusidic Acid 2%	Cream and Ointment High level of resistance in general population due to over use
04.07.03	Gabapentin	Capsule (100mg, 300mg and 400mg strengths)
04.08.01	Gabapentin
04.11	Galantamine Reminyl^®	Tablets 8mg, 16mg XL and 24mg XL, Oral liquid 4mg/ml Second Line for Mild to moderate Alzheimers disease Usual dose range 16-24mg Max daily dose 24mg XL Max sinlge dose 24mg XL
04.07.04.02	Galcanezumab Emgality	To be prescribed by neurology specialist As per NICE TA 659 - Galcanezumab for preventing migraine To be prescribed as per PAS price
05.03.02.02	Ganciclovir Cymevene^®
11.03.03	Ganciclovir 0.15% ophthalmic gel Virgan^®
01.01.02	Gaviscon	suspension, 3.1mmol sodium per 5ml
01.01.02	Gaviscon Advance	suspension, contains 2.3mmol sodium and 1mmol potassium per 5ml.
01.01.02	Gaviscon Infant	Oral powder, contains 0.92mmol sodium per dose NOTE: each half dual sachet is identified as one dose. To avoid errors prescribe in terms of 'dose'
08.01.05	Gefitinib Iressa^®	Available via a patient access scheme, please register patients when initiating treatment
09.02.02.02	Gelatin Gelofusine^®	Infusion 500ml and 1 litre bags available
09.02.02.02	Gelatin Haemaccel^®
12.03.01	Gelclair^®	Oral gel - sachets
08.01.03	Gemcitabine Gemzar^®
07.01.01	Gemeprost	Pessaries 1mg currently not available
05.01.04	Gentamicin
11.03.01	Gentamicin ophthalmic	Available as: - Eye drops 0.3% - Eye drops 0.3% (preservative free - unlicensed) Specialist use only
12.01.01	Gentamicin Genticin^®	Drops 0.3%
24.01	Gentamicin	Indication: Infection Dose: 4 mg/kg IV slow bolus >= 28/40 once daily <28/40 36hourly Administration IV injection over 3-5 minutes or infusion over 30 minutes Monitoring Levels before 3rd dose >=28/40 Levels before 2nd dose <28/40 Pre dose levels only (trough). Levels >2mg/L are considered undesirable, consider modifying dose interval if treatment is to be continued Levels are not necessary if it is likely gentamicin will be stopped at third dose for negative blood cultures. It is appropriate to stop blood cultures 36 hours or so after they have been taken, as opposed to when they were recorded as arriving in the lab, if baby was always well. Further Info: Gentamicin should be prescribed at 0600, 1200, 1800, 2400 times when being administered on postnatal wards, to minimise risk of maladministration. Supply: Available from pharmacy as a stock item. Ensure ONLY the 20mg in 2ml vial is used
06.01.02.01	Gliclazide	Tablet 40mg and 80mg Only 80mg tablets stocked at BTHFT If needed tablets can be crushed and dispersed in water. Liquid can be made specially if required.
06.01.02.01	Gliclazide MR	MR tablet 30mg Gliclazide mr/r 30mg approximately equivalent in therapeutic effect to standard formulation gliclazide 80mg
06.01.02.01	Glimepiride	Tablets 1mg, 2mg, 3mg and 4mg
06.01.04	Glucagon GlucaGen^® HypoKit	1 unit of glucagon = 1mg of glucagon
06.01.04	GlucoGel^®
09.02.02.01	Glucose Intravenous	Available in multiple strengths Infusion Dextrose 5% infusion 50ml, 100ml, 250ml, 500ml, 1 litre Dextrose 10% infusion 500ml Dextrose 20% infusion 100ml,500ml Dextrose 50% infusion 500ml Ampoules Dextrose 10% 10ml ampoules dextrose 50% 50ml ampoules
13.07	Glutaraldehyde Glutarol^®
01.06.02	Glycerol (Glycerin)	Suppository, available in 1g (infant), 2g (child) and 4g (adult)
02.06.01	Glyceryl Trinitrate	Available as Tablet (S/L & Buccal), Spray, Patches, Injection. Injection restricted (secondary care only)- Use Polyethylene (PE), giving set for infusion (NOT PVC!).
01.07.04	Glyceryl Trinitrate 0.4% Rectogesic^®	Ointment
07.04.04	Glycine
09.08.01	Glycine	Capsules Use by specialist metabolic service only
03.01.02	Glycopyrronium Seebri breezhaler^®	Inhalation capsule (50micrograms/dose) for use with Seebri Bteezhaler
15.01.03	Glycopyrronium
01.05.03	Golimumab Simponi ^®	To be used as per NICE guidelines: TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
10.01.03	Golimumab Simponi^®
13.05.03	Golimumab Simponi	As per NICE guidelines TA220: Golimumab for the treatment of psoriatic arthritis
06.05.01	Gonadorelin HRF^®
06.07.02	Goserelin	Subcut injection (implant) 3.6mg and 10.8mg
08.03.04.02	Goserelin Zoladex^®
08.03.04.02	Goserelin Zoladex^® LA
08.03.04.01	Goserelin-Zoladex^®
05.02	Griseofulvin
13.05.03	Guselkumab Tremfya	To be prescribed as per NICE guidelines for plaque psoriasis: TA521: Guselkumab for treating moderate to severe plaque psoriasis
09.08.02	Haem Arginate Normasang^®
14.04	Haemophilus influenzae type B Combined Vaccine Menitorix^®
04.02.01	Haloperidol	Tablets 0.5mg, 1.5mg, 5mg, 10mg Oral solution 10mg/5ml First generation anitpsychotic Management of acutely disturbed behaviour Usual ORAL dose range 1.5mg-5mg upto two to three times daily Max daily dose 30mg Max single dose 10mg
04.02.01	Haloperidol	Injection 5mg/ml (intramuscular) Management of acutely disturbed behaviour Usual dose range 2-10mg, then every 4-8hours according to response, Elderly initially half adult dose Max daily dose 12mg (reduced according BNF June 2014) Max single dose 2-10mg
04.02.02	Haloperidol Haldol Decanoate^®	Injection (oily) 50mg/ml and 100mg/ml
02.08.01	Heparin	Heparin sodium 10 units/ml (for IV line flushes only)
02.08.01	Heparin	Heparin sodium 1000 units/1mL.
14.04	Hepatitis A vaccine
14.04	Hepatitis A vaccine Single Component Avaxim^®
14.04	Hepatitis A vaccine Single Component Vaqta^® Paediatric
14.04	Hepatitis A vaccine with Hepatitis B vaccine Twinrix^®
14.05.02	Hepatitis B immunoglobulin	Obtain direct from LGI Virology Mon-Fri: 08.30-17:00 Tel: 0113-3928750/49 or 3928665 Out of Hours: Seacroft Lodge: 0113-2063283 (ask for Consultant Virologist)
14.04	Hepatitis B vaccine
14.04	Hepatitis B vaccine Single Component Engerix B^®
14.04	Hepatitis B vaccine Single Component HBvaxPRO^®
06.01.01.01	Humalog^® Insulin Lispro	Rapid acting recombiant human insulin analogue 10mL vial 3mL cartridge for Autopen^® Classic or HumaPen^® 3mL prefilled Humalog^® KwikPen
06.01.01.01	Humulin R^® Insulin 500 units in 1mL	Insulin 500 units in 1mL 20 ml vial (high strength) For use by specialist diabetic consultants
06.01.01.01	Humulin S^® Soluble insulin	Short acting human soluble insulin 10mL vial 3mL cartridge (for most Autopen® Classic or HumaPen®)
06.01.01.02	Humulin^® I Isophane Insulin	Intermediate/long acting human isophane insulin 10mL vial 3mL cartridge 3mL prefilled KwikPen
10.01	Hyaluronic acid Hyalgan^®
10.03.01	Hyaluronidase Hyalase^®
02.05.01	Hydralazine	Tablet 25mg, 50mg, Suspension 5mg/5ml
01.05.02	Hydrocortisone Colifoam^®
06.03.02	Hydrocortisone	Tablets 10mg and 20mg, Injection 100/ml if needed tablets can be dispersed in water
12.03.01	Hydrocortisone Corlan^®	Pellets 2.5mg
13.04	Hydrocortisone	Cream (0.5% and 1%), Ointment (0.5% and 1%) Mild
13.04	Hydrocortisone Hydromol^® HC Intensive
13.04	Hydrocortisone 1% with Clotrimazole 1% Canesten HC^®	Cream Mild with antifungal
13.04	Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort^®	Cream, Ointment cream stored in the fridge, ointment room temperature Mild with antifungal
13.04	Hydrocortisone 1%, Clioquinol 3% Vioform-Hydrocortisone^®
13.04	Hydrocortisone 1%, Urea 10% and Lactic Acid 5% Calmurid HC^®
10.01.02.02	Hydrocortisone acetate Hydrocortistab^®	Injection 25mg/ml
13.04	Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H^®	Cream Mild with antimicrobial
12.01.01	Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone^® HC	Drops
13.04	Hydrocortisone Butyrate Locoid^®
13.11.06	Hydrogen Peroxide Crystacide^®
13.11.06	Hydrogen Peroxide Solution BP
13.02.01	Hydromol^®	Cream, Ointment
13.02.01.01	Hydromol^® bath and shower
04.07.02	Hydromorphone Palladone^®	Capsules m/r
09.01.02	Hydroxocobalamin	IM Injection vitamin B12 of choice for therapy - retained in the body longer
08.01.05	Hydroxycarbamide
08.01.05	Hydroxycarbamide Hydrea^®
09.01.03	Hydroxycarbamide
10.01.03	Hydroxychloroquine	Tablet 200mg Tablets may be crushed and dispersed in water, liquid (unlicensed special) can be made specially if required.
13.05.03	Hydroxychloroquine	Oral medication SWYAPC shared care guidelines
11.08.01	Hydroxypropyl Guar Systane^®	Eye drops
03.04.01	Hydroxyzine	Tablets 10mg and 25mg, Liquid 10mg/5ml Drowsy antihistamine, longer duration of action than chlorphenamine
01.02	Hyoscine Butylbromide Buscopan^®	Tablets 10mg, Injection 20mg/ml
04.06	Hyoscine Hydrobromide
15.01.03	Hyoscine Hydrobromide
11.08.01	Hypromellose	Eye drops 0.3%
11.08.01	Hypromellose Isopto Alkaline^®	Eye drops 1%
11.08.01	Hypromellose Isopto Plain^®	Eye drops 0.5%
11.08.01	Hypromellose Optive Fusion	Eye drops For the treatment of severe dry eyes Only for use by opthalmic department Replaces use of Optive eye drops
11.08.01	Hypromellose 0.3% with Dextran 70 0.1% Tears naturale^®	Eye drops
06.01.01.02	Hypurin^® Bovine Isophane Isophane Insulin	Intermediate acting bovine insulin 10mL vial 3mL cartridge (fits AutoPen Classic)
06.01.01.01	Hypurin^® Bovine Neutral Soluble insulin	Short acting bovine (highly purified) soluble insulin 10ml vial 3ml cartidges for Autopen^® Classic
06.01.01.01	Hypurin^® Porcine Neutral Soluble insulin	Short acting porcine (highly purified) soluble insulin 10ml vial 3ml cartridge for Autopen^® classic
06.01.01.02	Hypurin^®Bovine Lente Insulin Zinc suspension	Long acting bovine insulin 10mL vial
06.06.02	Ibandronic Acid Bondronat^®	Tablet 50mg, Infusion 1mg/ml
06.06.02	Ibandronic Acid Bonviva^®	Tablets 150mg, Injection 1mg/ml Tablet 150mg once MONTHLY dose
08.01.05	Ibrutinib Imbruvica®	For use in line with NICE TA429 Complete full hepatitis B serology including hepatitis B core antibody status before initiation. If this is positive please refer to Dr Moreea/Dr Southern for advice (see MHRA Drug Safety Update below)
10.01.01	Ibuprofen	Tablet 200mg and 400mg, suspension (100mg/5ml)
24.01	Ibuprofen	Indication: Patent Ductus Arteriosus Dose: 10 mg/kg loading dose then, 5 mg/kg OD for 2 days Administration slow IV bolus or infuse over 15mins Oral can be considered if IV access is an issue. Monitoring Renal function, liver function, platlets and bilirubin Further Info: May be diluted in sodium chloride 0.9% or glucose 5% if necessary. Avoid steroids during course if possible. Supply: Available from pharmacy as a stock item. Double check strength! TWO strengths currently stocked due to manufacturer supply issues.
08.01.02	Idarubicin Hydrochloride Zavedos^®
09.08.01	Idursulfase Elaprase^®
08.01.01	Ifosfamide Mitoxana^®
02.05.01	Iloprost injection	Injection Restricted for vascular use
08.01.05	Imatinib Gilvec^®
24.01	Imipenem	Indication: Infection- Dose: 20 mg/kg dose < 7days BD 7 - 21 days TDS 21 - 28 days QDS Dose frequency should be reduced if renal failure suspected and stopped if patient anuric. Caution in CNS disorders Administration IV infusion over at least 30minutes Dilute to a concentration of 5mg/ml(imipenem) in sodium chloride 0.9% or glucose 5%. Monitoring Renal function, hypotension, seizures, myoclonic activity,thrombocytopenia, neurotoxicity(see neonatal formulary) Further Info: Also refered to as Imipenem with cilastatin. Prescribe in terms of Imipenem Supply: Available from pharmacy as a named patient.DSU cannot manufacturer.
04.03.01	Imipramine	Tablets 10mg, 25mg Usual dose range 75-200mg in divided doses Max daily dose 200mg (300mg in hospital) Max single dose 150mg
13.07	Imiquimod Aldara^®
24.01	Immunisations	See BNF-C share point document
14.04	Inactivated Influenza Vaccine (Split Virion)
03.01.01.01	Indacaterol	Inhalation pwder, hard capsule with device 150 and 300 microgrammes per inhalation Specialist initiation
02.02.01	Indapamide	Tablet 2.5mg, M/R tablets 1.5mg If needed standard tablets can be dispersed in water for patients with swallowing difficulties or enteral tubes terminating in the stomach. MR tablets should not be crushed.
05.03.01	Indinavir Crixivan^®
10.01.01	Indometacin	Tablets 25mg, 50mg
24.01	Indomethacin	IV NOT available, REVIEW?? Either: 200mcg/kg IV then 100mcg/kg daily for 5 days or 200mcg/kg repeated 12hourly x 3 doses in total Watch for renal and GI side effects. Make 100microgram / ml solution by diluting 1mg in 10ml 0.9% saline, use infusion pump to infuse appropriate dose over 20mins.
01.05.03	Infliximab Remsima	Remsima is the brand of choice at BTHFT, Remicade can only be prescribed if approved by DTC. Remsima is now available as an IV infusion and SC injection. For more information about dosing, contact the pharmacy or gastroenterology teams. To be used as per NICE guidelines: TA163: Infliximab for acute exacerbations of ulcerative colitis TA187: Infliximab and adalimumab for the treatment of Crohn's disease TA329: Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
10.01.03	Infliximab Remicade^®
13.05.03	Infliximab Remsima	Remsima is brand of choice at BTHFT. Remicade should only be prescribed if approved by DTC. Remsima is now available as an infusion and SC formulation. To be prescribed as per NICE guidelines for psoriasis/psoriatic arthritis: TA134: Infliximab for the treatment of adults with psoriasis TA199: Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
14.04	Influenza vaccine
24.01	Insulin Actrapid	Indication: Hyperglycaemia Dose: Dose range 0.02-0.1units/kg/hour Start at 0.05 units/kg/hour For hyperkalaemia 1 unit is needed for every 30g of glucose. Administration IV infusion 5 units of soluble insulin(Actrapid) into 50mls 5%dextrose(0.1units/ml) See “Insulin – making up and giving” guideline Monitoring Blood sugars, potassium, glucosuria and blood gases. Further Info: Prime lines and slowly flush with 10mls of infusion to prevent insulin binding to plastic. Insulin is generally given by a separate intravenous cannula, but when circumstances prevent this an insulin infusion may be connected aseptically to the ’lipid port’. Supply: Available from pharmacy as a stock vial. DSU cannot make due to product expiry.
06.01.01.02	Insuman^® Basal Isophane Insulin	Intermediate acting human isophane insulin 5ml vial 3ml cartridge 3ml SoloStar^® prefilled pen
06.01.01.01	Insuman^® Rapid Soluble insulin	Short acting human soluble insulin 3mL cartridge for ClikSTAR^® and Autopen^®
08.02.04	Interferon Alfa
08.02.04	Interferon Alfa Roferon-A^®
08.02.04	Interferon Alfa Viraferon^®	Initiated by hepatitis specialist team
07.03.04	Intra-uterine Contraceptive Devices Load^® 375
07.03.04	Intra-uterine Contraceptive Devices Nova-T^® 380
07.03.02.03	Intra-uterine Progestogen Only System Mirena^®	Intra-uterine device Releases Levonorgesterol 20 micrograms/24hours
06.02.02	Iodine and Iodide	Aqueous oral solution, total iodine 130mg/ml Also known as Lugol's iodine
03.01.02	Ipratropium	Inhaler CFC-free (20micrograms/dose), Nebuliser solution (250 and 500 micrograms/ml).
12.02.02	Ipratropium Bromide Rinatec^®	Nasal spray 0.03%, ipratropium bromide 21 micrograms/metered spray
02.05.05.02	Irbesartan	Tablets If needed tablets can be crushed and dispersed in water. Drug is poorly soluble
08.01.05	Irinotecan Hydrochloride Campto^®
09.01.01.02	Iron Dextran CosmoFer^®	Ferinject first line Only use if contraindicated to ferinject
09.01.01.02	Iron Sucrose Venofer^®	Ferinject first line Venofer is used first line for haemodialysis patients as they are having 100mg doses regularly, hence more cost effective for this indication
05.02.01	Isavuconazole	For use by infectious diseases and microbiology team only
15.01.02	Isoflurane
05.01.09	Isoniazid
06.01.01.02	Isophane Insulin Hypurin^® Porcine Isophane
06.01.01.02	Isophane Insulin Insulatard^®	10mL vial 3mL cartridge InnoLet
02.07.01	Isoprenaline	Infusion (secondary care only)
02.06.01	Isosorbide Dinitrate	Short acting tablet, spray Injection- 25mg/50ml ampoule (secondary care only) Use prepared solution of Isoket 0.05% (25mg/50ml ampoule). Administer by syringe pump. Start at 4ml/hour (2mg/hr). Increase the rate to a maximum of 20ml/hr (10mg/hr) if symptoms persist. decrease the rate if the systolic BP fall below 90mmHG For additional advice speak to CCU
02.06.01	Isosorbide Mononitrate	Tablet, MR tablet Short acting preparations should be prescribed asymmetrically to reduce the risk of nitrate tolerance If needed tablets can be crushed and dispersed in water. Do not crush MR tablets. MR is aonce daily, long acting preparation
13.06.01	Isotretinoin Isotrex^® gel
13.06.02	Isotretinoin Roaccutane^®	Specialist dermatology prescribers only
01.06.01	Ispaghula Husk	Granules
05.02	Itraconazole Sporanox^®
02.06.03	Ivabradine	Tablet 7.5mg and 15mg
13.06	Ivermectin Soolantra^®	Cream Topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients
13.10.04	Ivermectin
13.05.03	Ixekizumab Taltz^®	To be prescribed as per NICE guidelines: TA442: Ixekizumab for treating moderate to severe plaque psoriasis TA537: Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs
15.01.01	Ketamine injection Ketalar^®
13.09	Ketoconazole	Shampoo
13.10.02	Ketoconazole
11.08.02	Ketorolac Acular^®	Eye drops 0.5%
15.01.04.02	Ketorolac Toradol^®
11.04.02	Ketotifen Ketofall^®	Preservative free eye drop
01.06.05	Klean-Prep^®	Oral powder
02.04	Labetalol	Tablet, (Injection - secondary care only) If needed tablets can be crushed and dispersed in water. Administer immediately as drug is sensitive to oxidation.
04.08.01	Lacosamide Vimpat ^®
07.02.02	Lactic acid Balance Activ Rx^®	Vaginal gel
01.06.04	Lactulose	Solution
05.03.01	Lamivudine Zeffix^®
04.02.03	Lamotrigine	Tablets 25mg, 50mg, 100mg, 200mg ; dispersible tablets also available Usual dose range 50-200mg daily with valproate 100mg-400mg daily without valproate
04.08.01	Lamotrigine
08.03.04.03	Lanreotide Somatuline Autogel^®
08.03.04.03	Lanreotide Somatuline^® LA
01.03.05	Lansoprazole	Capsules first line, 15mg and 30mg Capsules can be opened and beads swallowed without crushing, or can be mixed with food or drink orodispersible tablets restricted for use in patients with swallowing difficulties or who are on enteral tube feeding. They are also licensed to be given via a NG tube or oral syringe if diluted in 5-10ml water
09.05.02.02	Lanthanum Fosrenol ^®	Tablet
06.01.01.02	Lantus^® Insulin Glargine	Intermediate/long acting recombinant human insulin analogue 10mL vial 3mL cartridge for ClikSTAR 3mL disposable prefilled pen - Solostar®
08.01.05	Lapatinib Tyverb^®	Lapatinib with capecitabine - VIA CDF - for locally reccurent or metastatic breast cancer
09.08.01	Laronidase Aldurazyme^®
11.06	Latanoprost	Eye drops 0.005%
11.06	Latanoprost Monopost^®	Eye drops 0.005% Preservative free Single dose 30x0.2ml Only for use in ophthalmics as a second line agent to standard latanoprost (preserved) where the patient has developed an allergy/intolerance to the preservative. Please also note that Saflutan (Tafluprost) (single dose/preserbvative free) will cease to be used.
11.06	Latanoprost 0.005% with timolol 0.5% Fixapost^®	Preservative free 0.2ml unit dose eye drop Opthalmology only To be used if patient reacts to preservative containing drops (latanoprost/timolol)
11.06	Latanoprost 0.005% with Timolol 0.5% Xalacom^®	Eye drops
10.01.03	Leflunomide
08.02.04	Lenalidomide
08.03.04.01	Letrozole
08.03.04.02	Leuprorelin Acetate Prostap^® SR
08.03.04.02	Leuprorelin Acetate Prostap^® 3
06.01.01.02	Levemir^® Insulin Detemir	Long acting recombinant human insulin analogue 3mL cartridge for NovoPen^® devices 3mL prefilled FlexPen^®
04.08.01	Levetiracetam
11.06	Levobunolol	Eye drops 0.5%
15.02	Levobupivacaine Chirocaine^®
04.09.01	Levodopa
05.01.12	Levofloxacin
11.03.01	Levofloxacin
04.02.01	Levomepromazine Nozinan^®
07.03.05	Levonogrestrel Levonelle^® 1500	Tablet 1.5mg Single dose as soon as possible after coitus preferbaly within 12 hours but no later than after 72 hours (3 days. May be used between 72 and 96 hours but efficacy decreases with time.
06.02.01	Levothyroxine	Tablets 25mcg, 50mcg,100mcg Liquid 25mcg/5ml, 50mcg/ml, 100mcg/5ml - significantly more expensive than tablets, only use where necessary If needed tablets can be crushed and dispersed in water
02.03.02	Lidocaine	Injection, Minijet(disposable syringe)
15.02	Lidocaine Versatis^®	Medicated plasters 5% Restricted for pain management service recommendation only Apply for 12 hours followed by a 12 hour plaster-free period Discontinue if no repsonse after 4 weeks
15.02	Lidocaine 2.5% with Prilocaine 2.5% EMLA^®
15.02	Lidocaine2% with Chlorhexidine 0.25% Instillagel^®
15.02	Lignocaine
01.06.07	Linaclotide Constella^®
06.01.02.03	Linagliptin Trajenta^®	Tablet 5mg First choice DPP4 inhibitor at BTHFT
05.01.07	Linezolid
06.02.01	Liothyronine	Available as tablets or injection Tablets. For specialist initiation. Discuss with endocrinologist before initiation. Similar action to levothyroxine but is ore rapidly metabolised and has more rapid effect. 20-25 microgrames is equivalent to 100 micrograms of levothyroxine Injection also known as triiodothyronine
11.08.01	Liquid Paraffin Lacri-Lube^®	Eye ointment Prescribe Xailin night (same formulation more cost effective)
11.08.01	Liquid Paraffin Xailin Night^®	Eye ointment
06.01.02.03	Liraglutide Victoza^®	injection 6mg/ml
02.05.05.01	Lisinopril	Tablets, Oral solution If needed tablets can be dispersed in water Oral solution, for genuine swallowing difficulties or NG tubes
04.02.03	Lithium Carbonate Camcolit^®	Tablets 250mg (Li 6.8 mmol), 400mg (Li 10.8mmol) Prescribe by brand Usual dose range 400-1200mg daily Max daily dose is adjustable
04.02.03	Lithium Carbonate Priadel^®	Tablets 250mg(Li 5.4mmol), 400mg (Li 10.8mmol) Prescribe by brand Usual dose range 400-1200mg daily Max daily dose is adjustable
04.02.03	Lithium Citrate Li-Liquid^®
04.02.03	Lithium Citrate Priadel^®	Liquid (priadel) 520mg/5ml (Li 5.4mmol/5ml) Prescribe by brand Usual dose range 400-1200mg daily ; 5mls = 200mg lithium carbonate
11.04.02	Lodoxamide Alomide^®	Eye drops 0.1%
04.03.01	Lofepramine	Tablets 70mg
08.01.01	Lomustine
01.04.02	Loperamide	Capsule 2mg, Tablets 2mg, Syrup (1mg/5ml)
03.04.01	Loratadine	Liquid 5mg/5ml Tablets not stocked, use desloratidine
04.01.02	Lorazepam	Tablet 1mg, 2.5mg Usual dose range: 1 to 4mgdaily in divided doses Max daily dose 4mg Max single dose 2mg
04.01.02	Lorazepam injection	injection 4mg/ml Usual dose range: 1 to 4mg daily in divided doses Max daily dose 4mg
15.01.04.01	Lorazepam
02.05.05.02	Losartan	Tablets 1st line choice ARB if patients haven't tolerated an ACE inhibitor Licensed for Renal protection in type 2 diabetic patients with nephropathy (macroalbuminuria) (unlike candesartan) If needed tablets can be crushed and dispersed in water
11.04.01	Loteprednol Lotemax^®	Eye drops 0.5%
01.06.07	Lubiprostone Amitiza^®	Capsules 24micrograms Only to be prescribed by Gastro/Colorectal consultants Treatment of chronic idiopathic constipation as per NICE criteria Adult over 18 years, 24 micrograms twice daily for 2 weeks
13.06.02	Lymecycline Tetralysal^®300	Capsules 408mg
01.06.04	Macrogol Movicol^®	Sachets
01.06.04	Macrogol Movicol^®- Half	Sachets
09.05.01.03	Magnesium Glycerophosphate	Tablet (unlicensed) Contains 4mmol magnesium per tablet Tablets can be crushed and dispersed in water.
09.05.01.03	Magnesium Sulphate
24.01	Magnesium Sulphate	Indication: Hypomagnesemia, PPHN Dose: For low magnesium (usually <0.5mmol/l) 100mg/kg bd IM or oral usually x 2 doses For PPHN loading dose 250mg/kg over 10 mins then 20-75 mg/kg/hour IV infusion Administration 4ml of magnesium sulphate 50%(2g or 8.2mmol) made up to 40 mls with glucose 10%.(50mg/ml) Monitoring High doses often produce hypotonia, respiratory depression, systemic as well as pulmonary vasodilation. Further Info: Supply: Available from pharmacy as ward stock. Magnesium Sulphate 50% comes as a 2ml or 10ml ampoule
13.10.05	Magnesium Sulphate Paste BP
01.01.01	Magnesium Trisilicate Mixture BP	Suspension, 6mmol sodium/10ml
01.06.04	Magrogol Movicol^® Paediatric	Sachets
02.02.05	Mannitol	IV infusion
05.03.01	Maraviroc
14.04	Measles, Mumps and Rubella Vaccine, Live (MMR)
01.02	Mebeverine Hydrochloride	135mg Tablet 200mg MR Tablet non-formulary Oral suspension also available (50mg/5ml) but significantly more expensive
01.02	Mebeverine Hydrochloride Colofac^® MR	Use mebeverine 135mg tablets
06.04.01.02	Medroxyprogesterone Acetate	Tablet 5mg and 10mg
07.03.02.02	Medroxyprogesterone Acetate Depo-Provera^®	Injection 150mg/ml
08.03.02	Medroxyprogesterone Acetate Provera^®
10.01.01	Mefenamic Acid	Capsules 250mg, Tablets 500mg
08.03.02	Megestrol Acetate Megace^®
04.01.01	Melatonin
08.01.01	Melphalan
04.11	Memantine Ebixa^®	Tablets 10mg and 20mg First Line for Moderate to Severe Alzheimers disease Usual dose range 10-20mg Max daily dose 20mg Max single dose 20mg
09.06.06	Menadiol Sodium Phosphate
14.04	Meningococcal group C conjugate vaccine
15.02	Mepivacaine Scandonest Plain^®
03.04.02	Mepolizumab Nucala^®	Initiation by specialist respiratory consultant for severe refractory eosinophilic asthma in adults only
04.07.02	Meptazinol Meptid^®
09.08.01	Mercaptamine Cystagon^®
01.05.03	Mercaptopurine	Tablets 50mg
08.01.03	Mercaptopurine
05.01.02.02	Meropenem
24.01	Meropenem	Indication: Infection Dose: <7days 40mg/kg 12 hourly >7days 40mg/kg 8 hourly >1 month 40mg/kg 8 hourly If renal failure of any severity is suspected, reduce dose and interval, see below: Mild (eGFR 26-50ml/min) 20mg/kg 12hourly Moderate (eGFR 10-25ml/min) 10mg/kg 12hourly Severe (eGFR <10ml/min) 10mg/kg 24houly Administration Dilute to 10mg/ml (using displacemnt values) in glucose 5% or sodium chloride 0.9%. IV infusion over 15-30minutes Monitoring Review renal function before prescribing and review daily: Further Info: Supply: Available from pharmacy as stock. DSU can supply named patient syringes.
01.05.01	Mesalazine Octasa^®	Tablets 400mg and 800mg
01.05.01	Mesalazine Mezavant^® XL	Tablets m/r, 1.2g Once daily dosing
01.05.01	Mesalazine Pentasa^®	Available as: 500mg, 1g modified-release tablets 1g, 2g, 4g modified-release granules sachets 1g rectal suppositories 1g/100ml enema
01.05.01	Mesalazine Salofalk^®	Granules 500mg, Enema 2g Salofalk tablets not stocked at BTHFT, use Octasa or Pentasa
08.01	Mesna
02.07.02	Metaraminol	Injection (secondary care only)
06.01.02.02	Metformin	Tablet 500mg, 850mg, Tablet MR 500mg, 750mg, 1000mg (for patients with proven GI intolerance), Oral powder 500mg, 1000mg If needed tablets may be crushed and dispersed in water or a powder formulation is now available.
04.07.02	Methadone	Tablet, Liquid For initiation by pain team only when used as an analgesic
04.10.03	Methadone	Liquid 1mg/ml sugar free Substance misuse Usual dose range 30-120mg Always confirm with patients substance misuse service or regular community pharmacy to confirm the dose before prescribing. Contact details for Bradford Substance Misuse: Bradford Substance Misuse Directory
01.05.03	Methotrexate	Tablets 2.5mg 2.5mg tablets preferred Cytotoxic, DO NOT crush and disperse in water
08.01.03	Methotrexate
10.01.03	Methotrexate
10.01.03	Methotrexate Metoject^®
13.05.03	Methotrexate	Oral medication - prescibed as 2.5mg tablets Methotrexate once-weekly for autoimmune diseases: new measures to reduce risk of fatal overdose due to inadvertent daily instead of weekly dosing SWYAPC shared care guidelines
02.05.02	Methyldopa	Tablet Should only be used for hypertension when other agents have failed or aren't suitable. If needed tablets can be crushed and dispersed in water. Crush thoroughly and flush tube well to prevent blockage.
01.06.06	Methylnaltrexone Relistor^®	Vials Restricted for management of intractable opioid induced constipation in patients not responding to usual laxative treatment - Palliative care teams only
04.04	Methylphenidate	Tablets Drug treatment of attention deficit hyperactivity disorder (ADHD) Concerta XL Usual dose range 18mg - 54mg Max daily dose 108mg Equasym XL usual dose range 10mg-60mg Max daily dose 90mg (unlicensed) Medikinet XL Usual dose range 10mg-60mg Max daily dose 90mg (unlicensed)
06.03.02	Methylprednisolone	Tablets 2mg, 4mg 16mg and 100mg Injection (solu-medrone) 40mg, 125mg, 500mg and 1g vial Intramuscular depot 40mg/ml
10.01.02.02	Methylprednisolone Acetate Depo-Medrone^®	Injection 40mg in 1mL Injection 80mg in 2mL
04.06	Metoclopramide	Tablet, Liquid, Injection Not recommended for patients under 20 years of age due to risk of dystonic reactions Metoclopramide should only be prescribed for short-term use (up to 5 days). For adults, the maximum dose in 24 hours is 30 mg (or 0.5 mg per kg bodyweight). Can be given S/C (unlicenced but accepted practice)
02.02.01	Metolazone	Tablet unlicensed Position statement: Can be used in combination with a loop diretic in severe heart failure. Initiation of the drug should occur after consultation with the Cardiology team. Close monitoring of renal function is required
02.04	Metoprolol	Tablet, MR tablet,(Injection - secondary care only) Heart failure- third line, where there is a perceived need to use a short acting cardioselective beta-blocker. If needed tablets can be crushed and dispersed in water. Do not crush/disperse MR tablets.
05.01.11	Metronidazole
05.04.03	Metronidazole
07.02.02	Metronidazole Zidoval^®	Vaginal gel 0.75% 40g pack with 5 applicators
13.10.01.02	Metronidazole
24.01	Metronidazole	Review dosing? BNFC? Indication: Anaerobic bacterial infection Dose: 15 mg/kg loading dose then: 7.5 mg/kg 12hourly(<28 days old) 7.5 mg/kg 8hourly(>28days old) Administration IV infusion over at least 15 minutes Monitoring Liver function, FBC, Further Info: Dose may need adjusting if baby on steroids or barbituates Supply: Available from pharmacy as stock.
13.10.01.02	Metronidazole 0.75%
06.07.03	Metyrapone Metopirone^®
07.02.02	Miconazole Gyno-Daktarin^®	Intravaginal Cream 2%
12.03.02	Miconazole Daktarin^®	Oral Gel
13.10.02	Miconazole
04.08.02	Midazolam
15.01.04.01	Midazolam	Injection 5mg/ml, 10mg/5ml Management of disturbed behaviour Max daily dose 2.5mg-7.5mg (15mg in 24 hours) Max single dose 7.5mg
24.01	Midazolam	Indication: Seizures, sedation Dose: May require a loading dose 60-150micrograms/kg/hour continous infusion Administration 10mg of midazolam into 50mls glucose 5%or 10% for continous infusion Monitoring Heart rate, hypotension, hypotonia, agitation, urine output, temp and . Further Info: Can accumulate in neonates, consider reducing dose after 24hours if continuious infusion likely to continue. Antidote: See Flumazenil Supply: Available from pharmacy as stock. DSU can make syringes on request. Controlled drug.
20	MIDAZOLAM buccal
02.07.02	MIDODRINE Tablets 2.5 mg, 5mg
07.01.02	Mifepristone Mifegyne^®	Tablet 200mg
05.01.03	Minocycline
05.01.03	Minocycline Minocin^® MR
07.04.02	Mirabegron Betmiga^®	Capsule 25mg and 50mg
04.03.04	Mirtazapine	Tablets 15mg, 30mg and 45mg Orodispersible tablets also avaialable
01.03.04	Misoprostol Cytotec^®	Tablet 200 micrograms Not first line for gastro protection
07.01.01	Misoprostol	Tablets
08.01.02	Mitomycin
11.99.99.99	Mitomycin C	Intravitreal Injection Unlicensed - prepared by aseptic unit
08.01.02	Mitoxantrone Onkotrone^®
08.01.02	Mitoxantrone (Mitozantrone)
15.01.05	Mivacurium Chloride
04.03.02	Moclobemide	Tablets 150mg and 300mg Usual dose range 150-600mg Max daily dose 600mg Max single dose 300mg
04.04	Modafinil Provigil^®
12.02.01	Mometasone Furoate Nasonex^®	Nasal spray 50micrograms per spray
13.04	Mometasone Furoate 0.1% Elocon^®	Cream, Ointment, Scalp lotion Potent
03.03.02	Montelukast Singulair^®	Tablet 10mg, Chewable tablet 5mg, Granules 4mg
04.07.02	Morphine	Normal relase (~4 hours effect): Oral solution (e.g. Oramorph®), Tablet (Sevredol®) - Slow release (~12hr effect): Morphgesic Tablet MR 10mg, 30mg, 60mg, 100mg, 200mg, (MST® Tablet MR 5mg and 15mg ONLY), Injection. First line strong opioid
24.01	Morphine Sulphate	Indication: Sedation, analgesia Dose: 20 microcrams/kg/hr Dose range of 5 - 20 microcrams/kg/hr is normally prescribed Administration IV infusion Standard stock syringes are 2.5mg in 50mls glucose 5% (50micrograms/ml) Monitoring Respiratory rate, blood pressure,temperature and agitation. Further Info: Prescribe concentration, rate and dose Antidote: See Naloxone Compatibility: Glucose 5%, Glucose 10%, Sodium chloride 0.9%,Adrenaline, Aminophylline, Amiodarone, Calcium chloride, Dobutamine, Fentanyl, Insulin, Magnesium sulphate, Midazolam, Potassium chloride Supply: Available from DSU as a stock syringe. Order every Tuesday. 1mg in 50ml diluent is also available on named requests.
24.01	Morphine Sulphate Neonatal Abstinence Syndrome	Indication: Neonatal Abstinence Syndrome Dose: Start: 40 micrograms/kg/dose 4 hourly review daily Reduce as soon as tolerable to: 30 micrograms/kg/dose 4 hourly then 20 micrograms/kg/dose 4 hourly then 10 micrograms/kg/dose 4 hourly then stop. Discuss sedative use with consultant before starting. Administration Oral solution(100micorgrams in 1ml) Monitoring Respiratory rate, blood pressure,temperature and agitation. Further Info: Supply: Available from DSU as a stock item. M2(TCU) hold stock for OOH use.
01.06.05	Moviprep^®	Oral powder sachets Restricted to use as a bowel prep prior to colonoscopy
05.01.12	Moxifloxacin	For frug resistant Tuberculosis, seek advice from infectious diseases
05.01.12	Moxifloxacin
02.05.02	Moxonidine	Tablet Restricted for resistant or refractory cases If needed tablets can be crushed and dispersed in 50ml water. Crush thoroughly and disperse well before administering to prevent tube blockage.
09.06.07	Multivitamin
09.06.07	Multivitamin preparations Dalivit^®
09.06.07	Multivitamin preparations Abidec^®
13.10.01.01	Mupirocin	Ointment and Cream
08.02.01	Mycophenolate Mofetil CellCept^®
08.02.01	Mycophenolate Sodium Myfortic^®
02.06.04	Naftidrofuryl Oxalate
15.01.07	Naloxone
18	Naloxone
04.10.03	Naltrexone
10.01.01	Naproxen	Tablets 250mg, 500mg.
12.02.03	Naseptin^® Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5%	Cream Should not be used in patients with a peanut allergy MRSA suppression: Four times daily for 10 days
08.02.04	Natalizumab Tysabri^®
02.04	Nebivolol Nebilet^®	Tablet Specialist initiation only Tablets can be crushed and mixed with water for administration
11.04.02	Neodocromil Rapitil^®	Eye drops 2%
10.02.01	Neostigmine
15.01.06	Neostigmine
15.01.06	Neostigmine with Glycopyrronium
02.06.03	Nicorandil	Tablet 10mg and 20mg If needed tablets can be crushed and dispersed in water
04.10	Nicotine Nicotinell^®
04.10.02	Nicotine
02.06.02	Nifedipine	Tablets, MR tablets, capsules, MR capsules Prescribe by brand according to medicines policy
08.01.05	Nilotinib Tasigna^®
02.06.02	Nimodipine Nimotop^®	Tablet Injection- use Polyethylene (PE) giving set for infusion (NOT PVC!) Specialist use in secondary care only If needed tablets can be crushed and dispersed in water. Give immediately as rapid degradation occurs.
04.01.01	Nitrazepam	Tablets 5mg, suspension 2.5mg/5ml Usual dose range: 5-10mg at night Max daily dose 10mg Max single dose 10mg
05.01.13	Nitrofurantoin
15.01.02	Nitrous oxide
08.01	Nivolumab Opdivo^®	For use in line with NICE TA384, TA400 & TA417
02.07.02	Noradrenaline / Norepinephrine	Injection (secondary care only)
06.04.01.02	Norethisterone	Tablet 5mg
08.03.02	Norethisterone
14.05.01	Normal immunoglobulin for Intramuscular use
14.05.01	Normal immunoglobulin for Intravenous use
14.05.01	Normal immunoglobulin for Subcutaneous use
04.03.01	Nortriptyline
06.01.01.01	NovoRapid^® Insulin Aspart	Rapid acting recombinant human insulin analogue 10mL vial 3mL Penfill^® cartridge for NovoPen^® devices 3mL prefilled Flexpen^® 3ml prefilled FlexTouch^® pen
A2.05.02	Nutilis^® Powder	For adult renal patients or patients on a sodium restricted diet Contact the speach and language therapists (SALT) team for futher information and advice
13.04	Nystaform-HC^®	Cream, Ointment Mild with antimicrobial Cream contains 0.5% hydrocortisone, Ointment contain 1% useful for facial eczema in children
12.03.02	Nystatin Nystan^®	Oral suspension 100 000 units per mL
13.10.02	Nystatin
24.01	Nystatin	Indication: Prophylaxis for ventilated babies < 1500g with central lines. Treatment of oral and perioral fungal infections Dose: Prophylaxis: 50,000units TDS Treatment: 100,000units QDS usually for 7 days, and continued for 48 hours after lesions have healed. Administration Oral Monitoring Further Info: Document on drug chart indication(Prophylaxis or treatment) If bottle or breast fed administer after feed. Consider treament for breast feeding mums. Supply: Available from pharmacy as a stock item.(100,000units in 1ml)
13.10.02	Nystatin 100,000 uints/g Nystan^®
13.10.02	Nystatin with Chlorhexidine cream Nystaform^®
01.09.01	Obeticholic acid Ocaliva^®	Restricted for treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.
11.08.02	Ocriplasmin Jetrea^®
13.11	Octenisan^®	Skin antisepsis For patients requiring prolonged use or recurrent applications (due to multiple admissions), those with sensitive skin or immobile bedbound patients MRSA suppression: use once daily for duration of admission
08.03.04.03	Octreotide Sandostatin^®
08.03.04.03	Octreotide Sandostatin Lar^®
06.04.01.01	Oestrogen only HRT gel Oestrogel^®
06.04.01.01	Oestrogen only HRT patch Estradot^®, Evorel^®
06.04.01.01	Oestrogen only HRT tablet Elleste-Solo^®, Premarin^®
06.04.01.01	Oestrogens for HRT Elleste-Solo^® MX
07.02.01	Oestrogens, Topical Gynest^®	Intravaginal cream: estriol 0.01% (10x weaker than Ovestin)
07.02.01	Oestrogens, Topical Ovestin^®	Intravaginal cream: estriol 0.1% (10x stronger than Gynest)
07.02.01	Oestrogens, Topical Vagifem^®	Vaginal tablet: estradiol 10mcg 25 mcg strength was discontinued end 2012. 10mcg considered as efficacious
08.02.03	Ofatumumab Arzerra^®
05.01.12	Ofloxacin
11.03.01	Ofloxacin Eye drops Exocin^®	eye drops 0.3%
13.02.01	Oilatum^®	Cream, Shower gel, emmolient bath oil
13.02.01.01	Oilatum^® Plus emollient bath additive
01.07.03	Oily phenol injection BP	Injection
04.02.01	Olanzapine Zyprexa^®	Tablets 2.5mg, 5mg, 10mg, 15mg, 20mg ; dispersible tablets also available (significantly more expensive) second generation antipsychotic Usual dose range 5-20mg daily Max daily dose 20mg Max single dose 20mg
04.02.02	Olanzapine Embonate ZypAdhera^®
12.01.03	Olive Oil Ear Drops	Drops
03.04.02	Omalizumab Xolair^®	Specialist use only
13.05.03	Omalizumab Xolair	As per NICE guidelines: TA339: Omalizumab for previously treated chronic spontaneous urticaria
02.12	Omega-3-Acid Ethyl Esters Omacor^®
01.03.05	Omeprazole	Capsules first line 10mg, 20mg and 40mg Capsules can be opened and beads swallowed without crushing, or can be mixed with food or drink orodispersible tablets restricted for use in patients with swallowing difficulties or who are on enteral tube feeding and first choice lansoprazole is not suitable
01.03.05	Omeprazole IV	Restricted as per guideline - See Upper GI Bleeds Clinical Pathway (below)
04.06	Ondansetron	Tablets, injection, syrup and orodispersible film.
04.09.01	Opicapone Ongentys^®	2nd line where entacapone not appropriate, tolerated or effective or in those with mild-moderate liver impairment
07.03.02.01	Oral Progestogen Only Contraceptives Cerazette^®, Zelleta^®	Prescribe by brand, Zelleta^® preferred brand at BTHFT
07.03.02.01	Oral Progestogen Only Contraceptives Micronor^®
07.03.02.01	Oral Progestogen Only Contraceptives Norgeston^®
07.03.02	Oral Progestogen-Only Contraceptives Femulen^®	Tablet, etynodiol diacetate 500 micrograms
07.03.02	Oral Progestogen-Only Contraceptives Norgeston^®
07.03.02	Oral Progestogen-Only Contraceptives Cerazette^®
07.03.02	Oral Progestogen-Only Contraceptives Micronor^®	Tablet, norethisterone 350 micrograms
09.02.01.02	Oral Rehydration Salts Dioralyte^®	oral powder
08.01.05	Oxaliplatin
11.07	Oxybuprocaine Hydrochloride Minims^®
07.04.02	Oxybutynin	Tablet 2.5mg and 5mg Modified release 5mg and 10mg
07.04.02	Oxybutynin Hydrochloride Kentera^®	Patch 36mg (releasing approx 3.9mg/24 hours) Change patch twice weekly (every 3-4 days)
04.07.02	Oxycodone	Normal release: Capsule (OxyNorm), Liquid, Concentrate liquid, Injection Slow release: Tablet (OxyContin) Not first line strong opioid More expensive, and not superior to morphine. Only for patients unable to tolerate idiosyncratic side effects with morphine. Always give prophylactic laxatives
05.01.03	Oxytetracycline
13.06.02	Oxytetracycline	Tablets 250mg
07.01.01	Oxytocin Syntocinon^®	Injection 5units/ml
08.01.05	Paclitaxel Abraxane^®	NAB-Paclitaxel- Normal Albumin Bound – Paclitaxel . Dosing NOT interchangeable with “normal” paclitaxel Used in Combination with Gemcitabine for Pancreatic Cancer – VIA CDF Approved for Breast Cancer
08.01.05	Paclitaxel
04.02.02	Paliperidone Xeplion^®
05.03.05	Palivizumab Synagis^®
04.06	Palonosetron with netupitant Akynzeo^®	Palonosetron 0.5mg with netupitant 300mg For use by oncology team only Anti-emetic for use with cancer chemotherapy
04.06	Palonosetron with netupitant Akynzeo^®	Palonosetron 0.5mg with netupitant 300mg For use by oncology team only Anti-emetic for use with cancer chemotherapy
01.09.04	Pancreatin Creon^® Micro	Granules Only for paediatrics All pancreatin products contain pancreatin from a porcine source, currently an alternative is not available.
01.09.04	Pancreatin Creon^® 10000, 25000, 40000	Capsule All pancreatin products contain pancreatin from a porcine source, currently an alternative is not available.
24.01	Pancuronium	Indication: Muscle relaxation Dose: 100-200 micrograms/kg/dose PRN Administration IV bolus over 30seconds Dilute 1ml to 10ml with sodium chloride 0.9% or glucose 5% (200micrograms in 1ml) Monitoring Blood pressure, ventilation requiremnts may increase. Further Info: Longer acting than atracurium Antidote: See Neonatal Formulary 6th Ed Supply: Available from pharmacy as stock (2000 micrograms in 1ml)
15.01.05	Pancuronium Bromide
08.01.05	Panitumumab	For use in line with NICE TA439 Patient Access Scheme available for this treatment (in line with NICE TA439)
01.03.05	Pantoprazole	Tablets, 20mg and 40mg
01.03.05	Pantoprazole IV	Restricted as per guideline - See Upper GI Bleeds Clinical Pathway (below)
04.07.01	Paracetamol Perfalgan^®
04.07.01	Paracetamol	Tablet, Soluble tablet, Injection, Liquid, Suppositories The dose of IV paracetamol should be reduced in patients weighing less than 50Kg, the dose should be calculated as 15mg/kg four times a day. The maximum daily infusion dose should be 3g in patients greater than 50 kg body-weight who have risk factors for hepatotoxicity such as: alcohol dependence; hepatocellular insufficiency, chronic alcoholism, chronic malnutrition, or dehydration.
24.01	Paracetamol	Indication: Analgesia for mild to moderate pain. Dose: IV Preterm: >32/40 7.5mg/kg every 8hours(Max 25mg/kg in 24hours) Term: 10mg/kg every 4-6 hours(Max 30mg/kg in 24hours) Oral Preterm 28-32/40 10-15mg/kg every 8 to 12 hours(Max 30mg/kg in 24hours) Preterm >32/40 10-15mg/kg every 6 to 8 hours(Max 60mg/kg in 24hours) Indicate maximum daily dose in 24hours on chart Administration IV infusion over 15minutes Monitoring Blood pressure,heart rate(tachycardia),Liver Function, Renal function Further Info: Give undiluted or dilute to a concentration of not less than 1 mg/mL in Glucose 5% or Sodium Chloride 0.9%; use within 30minutes of dilution Supply: Available from pharmacy as a name pateint request. Supplied as 500mg in 50ml vial (10mg/ml)
04.07.01	Paracetamol and codeine Co-codamol^® 8/500	Tablet, Soluble tablet.
04.07.01	Paracetamol and codeine Co-codamol^® 30/500	Tablet, Effervescent tablet
15.01.04.02	Parecoxib Dynastat^®
24.03	Parenteral Nutrition	See current sharepoint protocol
09.06.04	Paricalcitol
04.03.03	Paroxetine	Tablets 10mg, 20mg and 30mg Usual dose range 20-50mg daily Max daily dose 50mg Max single dose 50mg
09.02.01.01	Patiromer sorbitex calcium Veltassa^®	8.4g and 16.8g sachets For treatment of acute and chronic hyperkalaemia
14.04	Pediacel^®
08.02.04	Peginterferon Alfa Pegasys^®	Initiated by hepatitis specialist team
08.02.03	Pembrolizumab KeyTruda^®	For use in line with NICE TA357, NICE TA366, NICE TA428 & TA447
08.01.03	Pemetrexed Alimta^®	Maintenance pemetrexed available through the CDF
09.08.01	Penicillamine
10.01.03	Penicillamine
08.01.05	Pentostatin Nipent^®
01.02	Peppermint Oil	Colpermin^® Colpermin brand contains arachis (peanut) oil Peppermint oil 0.2ml Capsule, MR, EC Mintec^® Peppermint oil 0.2ml Capsule, EC
01.02	Peppermint water	Solution unlicensed
04.08.01	Perampanel Fycompa^®	For initiation by consultant neurologist only
13.10.04	Permethrin 1% Lyclear^® Creme Rinse
13.10.04	Permethrin 5%	Dermal Cream
08.01.05	Pertuzumab Perjeta^®	1st line treatment of locally advanced or metastatic breast cancer
04.07.02	Pethidine	Tablet, Injection preferred in obstetrics
04.03.02	Phenelzine	Tablets 15mg Usual dose range :aim for lowest possible maintenace dose Max daily dose 90mg Max single dose 30mg
02.08.02	Phenindione	Tablet For patients intolerant of warfarin
04.08.01	Phenobarbital
04.08.02	Phenobarbital
24.01	Phenobarbital Phenobarbitone	Indication: Seizures Dose: 20 mg/kg loading dose 5 mg/kg/day maintenance Administration IV over at least 20minutes(no faster than 1mg/kg/minute) Take 1ml of 200mg/ml and dilute to 10ml with water for injection(20mg in 1ml) Monitoring Blood pressure(Hypotension, respiratory rate Blood Levels 20 - 40mg/l Further Info: Supply: Available from pharmacy as stock (200mg in 1ml)
02.05.04	Phenoxybenzamine Hydrochloride	Capsules Specialist use only for hypertensive episodes in phaeochromocytoma
05.01.01.01	Phenoxymethylpenicillin
A2.07	Phenylalanine Amino Acid Supplement
02.07.02	Phenylephrine	Injection not stocked within BTHFT
11.05	Phenylephrine Hydrochloride	Minims^®Phenylephrine Hydrochloride 2.5% and 10% single use eye drops
04.08.01	Phenytoin
04.08.01	Phenytoin Epanutin^®
24.01	Phenytoin	Indication: Seizures Dose: IV Loading dose 15 mg/kg Maintenance 2.5 mg/kg bd Administration IV(ideally centrally) over at least 15 mins(Max rate 1mg/kg/min) May be diluted if required using sodium chlorde 0.9% ONLY to a maximium concentration of 10mg in 1ml. A filter of 0.22 -0.5micron must be used for diluted IV phenytoin. Monitoring Metabolism increases over 5-7 weeks then stabilises, dosage increases will be necessary during this time. Monitor levels Trough level 40-80 mmols/L or 6-15mg/L Further Info: Not compatible with glucose. Flush line with sodium chloride 0.9% before and after administratrion. Oral dose should only be given 30minutes before or after feeds. Supply: Available from pharmacy as a stock item.
03.09.01	Pholcodine Linctus, BP	Linctus for a dry cough
09.05.02.01	Phosphate supplements Phosphate-Sandoz^®	Effervescent tablet Contains 16.1mmol phosphate, 20.4mmol sodium and 3.1mmol potassium per tablet
01.06.04	Phosphates (Rectal) Fleet^® Ready to use Enema	Enema
09.06.06	Phytomenadione
09.06.06	Phytomenadione Konakion^® MM
09.06.06	Phytomenadione Konakion^® MM Paediatric
11.06	Pilocarpine	Eye drops 1% and 2% Minims single use 2%
12.03.05	pilocarpine Hydrochloride Salagen^®
11.06	Pilocarpine preservative free
13.05.03	Pimecrolimus Elidel^®	Cream 1%
06.01.02.03	Pioglitazone Actos^®	Tablets 15mg, 30mg, 45mg
05.01.01.04	Piperacillin and Tazobactam
04.02.02	Pipotiazine Palmitate Piportil^® Depot	Depot injection
04.09.03	Piracetam Nootropil^®	Restricted for initiation by or on the advice of a consultant paediatric neurologist
10.01.01	Piroxicam
10.03.02	Piroxicam	0.5% gel
05.01.01.05	Pivmecillinam Hydrochloride Selexid^®
04.07.04.02	Pizotifen	Tablets 0.5mg and 1.5mg
09.01.07	Plerixafor
14.04	Pneumococcal polysaccharide conjugate vaccine (adsorbed) Prevenar 13^®
14.04	Pneumovax^® II
13.07	Podophyllotoxin Condyline^®
13.07	Podophyllotoxin Warticon^®
06.01.06	Polycal^®	Powder Available for Glucose Tolerance Test. To be given as 113ml Polycal® liquid diluted with water to a total volume of 200-300ml (see BNF).
09.02.01.01	Polystyrene sulphonate resins Calcium Resonium^®	300g tub. Includes a 15g scoop For treatment of acute and chronic hyperkalaemia Due to be replaced by patiromer sorbitex calcium (Veltassa^®)
13.09	Polytar^®	Discontinued
11.08.01	Polyvinyl Alchohol SnoTears^®	Eye drops
08.02.04	Pomalidomide
08.01.05	Ponatinib Iclusig^®	For use in line with NICE TA451
03.05.02	Poractant Alfa Curosurf^®	Suspension For specialist use only Porcine lung extract
05.02	Posaconazole Noxafil^®
09.02.01.01	Potassium Chloride Kay-Cee-L^®	Syrup 1mL = 1mmol of K+
09.02.01.01	Potassium Chloride Sando-K^®	Tablet 1 tablet = 12mmol of K+
09.02.02.01	Potassium Chloride and Glucose Intravenous Infusion	Available in multiple strengths Potassium Chloride 10mmol in 500mL with Dextrose 5% (20mmol per litre) Potassium Chloride 10mmol in 500mL with Dextrose 10% (20mmol per litre) Potassium Chloride 20mmol in 500mL with Dextrose 5% (40mmol per litre) Potassium Chloride 20mmol in 500mL with Dextrose 10% (40mmol per litre) Potassium Chloride 20mmol in 1000mL with Dextrose 5% (20mmol per litre) Potassium Chloride 40mmol in 500mL with Dextrose 5% (80mmol per litre) Potassium Chloride 40mmol in 1000mL with Dextrose 5% (40mmol per litre)
09.02.02.01	Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion	Available in multiple strengths Potassium Chloride 10mmol in 500mL with Dextrose 4% & Sodium Chloride 0.18% (20mmol per litre) Potassium Chloride 10mmol in 500mL with Dextrose 5% & Sodium Chloride 0.45% (20mmol per litre) Potassium Chloride 20mmol in 500mL with Dextrose 5% & Sodium Chloride 0.45% (40mmol per litre) Potassium Chloride 20mmol in 1000mL with Dextrose 2.5% & Sodium Chloride 0.45% (20mmol per litre) Potassium Chloride 20mmol in 500mL with Dextrose 4% & Sodium Chloride 0.18% (40mmol per litre) Potassium Chloride 20mmol in 1000mL with Dextrose 4% & Sodium Chloride 0.18% (20mmol per litre) Potassium Chloride 40mmol in 1000mL with Dextrose 4% & Sodium Chloride 0.18% (40mmol per litre)
07.04.03	Potassium Citrate	Oral solution , potassium citrate 30% and citric acid 5% 10ml TDS well diltuted with water for alkalinsation of urine Sachets also available
13.11.06	Potassium Permanganate Permitabs^®
13.11.04	Povidone-Iodine Betadine^® or Videne^®
13.11.04	Povidone-Iodine Savlon^® Dry Antiseptic
04.09.01	Pramipexole
02.09	Prasugrel	Tablet (position statement from cardiology to add)
02.12	Pravastatin	Tablet If needed tablets can be crushed and dispersed in water
02.05.04	Prazosin
01.05.02	Prednisolone
01.05.02	Prednisolone	Tablets
06.03.02	Prednisolone	Tablets 1mg, 2.5mg, 5mg, 25mg and soluble Tablets 5mg EC tablets 6x the price of plain tablets without any substantial evidence that they confer any GI benefits Soluble tablets 15x more expensive than normal tablets
08.02.02	Prednisolone
11.04.01	Prednisolone	Eye drops 0.5% Predsol^® (eye and ear drops); Minims^® Prednisolone Sodium Phosphate(Bausch & Lomb) 1% Pred Forte^®
12.01.01	Prednisolone 0.5% with Neomycin 0.5% Predsol-N^®	Discontinued in the UK
11.04.01	Prednisolone 0.5% with Neomycin 0.5% Predsol-N^®
12.01.01	Prednisolone ear drops Predsol^®	Drops 0.5%
11.04.01	Prednisolone preservative free eye drops
04.02.03	Pregabalin	Capsules 25mg, 75mg, 150mg, 225mg and 300mg For generalised anxiety disorder Usual dose range 150-600mg daily in two to three divided doses max daily dose 600mg max single dose 300mg
04.07.03	Pregabalin	Capsule Should only be considered after both amitriptyline and gabapentin have failed at optimised doses. If needed capsules can be opened and contents dispersed in water.
04.08.01	Pregabalin
15.02	Prilocaine Hydrochloride Citanest^®
04.08.01	Primidone Mysoline^®
10.01.04	Probenecid
24.01	Probiotic Infloran^®	Indication: Prevention of necrotizing enterocolitis (NEC) Dose: 1/2 capsule ONCE a day with feeds Administration: Add Infloran to 2ml milk or water (1 capsule) (EBM / donor or formula) prior to feeds. Administer half the volume. If administered mixed with water, give additional to feeds. Further Info: As soon as a baby has commenced enteral feeds, and is thought to be tolerating 0.5mls/h of milk. Probiotics can be stopped once the baby is 34 weeks corrected gestation providing the baby has been tolerating enteral feeds for the 2 weeks prior to this date Supply: Available on NNU as a stock item. Stored in Fridge
08.01.05	Procarbazine
04.02.01	Prochlorperazine
04.06	Prochlorperazine	Tablet Buccal tablet Injection (IM route only. Not for IV or SC use.)
04.06	Prochlorperazine Buccastem^® (Bucal preparation)
01.07.02	Proctosedyl	Ointment and Suppository Ointment - cinchocaine 0.5% and hydrocortisone 0.5% Suppositories - cinchocaine 5mg and hydrocortisone 5mg
04.09.02	Procyclidine
13.10.05	Proflavine Cream, BPC
06.04.01.02	Progesterone Cyclogest^®	pessaries 200mg and 400mg
06.04.01.02	Progesterone Gestone^®
04.02.01	Promazine Hydrochloride Promazine^®	Tablet 25mg, Oral solution 25 mg/5 mL First generation antipsychotic Usual dose range 100-200mg up to four times daily Max daily dose 800mg Max single dose 200mg
03.04.01	Promethazine	Tablets 10mg, 25mg, Liquid 5mg/5ml, Injection 25mg/ml Promethazine Teoclate (avomine) preferred in pregnancy rather than Promethazine Hydrochloride
04.06	Promethazine Hydrochloride Phenergan	Tablets 10mg and 25mg
04.01.01	Promethazine Hydrochloride	Tablets 10mg, 25mg Usual dose range: 10-25mg at night Max daily dose 50mg Max single dose 50mg
13.11	Prontoderm^® Foam	Skin antisepsis For patients requiring prolonged use or recurrent applications (due to multiple admissions), those with sensitive skin or immobile bedbound patients MRSA suppression: use once daily for duration of admission
12.02.03	Prontoderm^® Nasal Gel	Nasal gel For patients who cannot use Naseptin^® nasal cream while Bactroban^® is unavailable MRSA suppression: Three times daily for 5 days
02.03.02	Propafenone	Cardiology use only
11.03.01	Propamidine Isetionate Brolene^®	Eye drops 0.1%
15.01.01	Propofol
15.01.01	Propofol Diprivan^®
02.04	Propranolol	Tablet, Capsule MR, Liquid, (Injection - secondary care only) If needed MR capsules can be opened and beads mixed with water - do not crush.
04.07.04.02	Propranolol	Tablets 10mg, 40mg
06.02.02	Propylthiouracil	Tablets 50mg
02.08.03	Protamine Sulphate	Injection (secondary care only) Remember maximum dose is 50mg. To be given by slow intravenous injection over 10 minutes.
11.07	Proxymetacaine Hydrochloride Minims^®	Eye drops
11.07	Proxymetacaine Hydrochloride 0.5% with Fluorescein Sodium 0.25% Minims^®	Eye drops
01.06.07	Prucalopride Resolor ^®	Tablet Restricted to gastroenterology consultant initiation for treatment of chronic, resistant constipation in WOMEN in line with NICE guidance (see below)
05.01.09	Pyrazinamide
10.02.01	Pyridostigmine Bromide Mestinon^®
09.06.02	Pyridoxine Hydrochloride
04.02.01	Quetiapine Seroquel^®	Tablets 50mg, 100mg, 150mg, 300mg, 400mg. Modified release (XL) tablets also available, but siginificantly more expensive Second generation anitpsychotic Usual dose range 300mg-600mg max daily dose 800mg plain tablets or 800mg XL
06.07.01	Quinagolide Norprolac^®	Tablets 75 microgram (white) Starter pack contains 3 x 25microgram (pink) with 3 x 50microgram (blue)
05.04.01	Quinine
10.02.02	Quinine
06.04.01.01	Raloxifene Hydrochloride Evista^®	Tablet 60mg
08.01.03	Raltitrexed Tomudex^®
02.05.05.01	Ramipril	Capsule, Oral solution If needed capsules can be opened and the contents mixed with water. Oral solution, for genuine swallowing difficulties or NG tubes
11.08.02	Ranibizumab Lucentis^®	Intravitreal injection
01.03.01	Ranitidine	Tablet 150mg and 300mg, soluble tablet 150mg and 300mg, Syrup 75mg/5ml, Injection 25mg/ml
24.01	Ranitidine	IV 500mcg/kg slow bolus qds or IV infusion 125 mcg/kg/hour or oral 2 mg/kg tds
02.06.03	Ranolazine	Tablets 375mg and 500mg following specialist recommendation
04.09.01	Rasagiline Azilect^®
10.01.04	Rasburicase Fastertec^®
04.03.04	Reboxetine Edronex^®	Tablets 4mg Usual dose range 4mg twice daily Max daily dose 12mg Max single dose 6mg
15.01.04.03	Remifentanil
06.01.02.03	Repaglinide	Tablets 0.5mg, 1mg and 2mg
A2.05.02	Resource^® ThickenUp Clear	To be lauched as first line thickener for adult patients November 2018 Contact the speach and language therapists (SALT) team for futher information and advice
04.08.01	Retigabine
14.04	Revaxis^®
05.03.05	Ribavirin
05.01.09	Rifampicin
05.01.09	Rifampicin and Isoniazid Rifinah^® 300
05.01.09	Rifampicin and Isoniazid Rifinah^® 150
05.01.09	Rifampicin and Isoniazid and Pyrazinamide Rifater^®
05.01.09	Rifampicin, isoniazid, pyrazinamide and ethambutol Voractiv^®
04.09.03	Riluzole
11.04.01	Rimexolone Vexol^®	Eye drops 1%
13.05.03	Risankizumab Skyrizi	As per NICE guidelines: TA596: Risankizumab for treating moderate to severe plaque psoriasis
06.06.02	Risedronate
04.02.01	Risperidone Risperdal^®	Tablets,500 micrograms,1 mg, 2 mg, 3 mg, 4 mg, 6 mg Orodispersible tablets also available Liquid 1 mg/mL Note Liquid may be diluted with any non-alcoholic drink, except tea Second generation antipsychotic Initially 2mg daily Usual dose range 4-6mg daily Max daily dose 16mg, no benefit generally seen above 10mg daily
04.02.02	Risperidone Risperdal Consta^®
05.03.01	Ritonavir Norvir^®
08.02.03	Rituximab MabThera^®
10.01.03	Rituximab (rheumatology) MabThera^®
02.08.02	Rivaroxaban	Treatment of DVT or PE: GPs may initiate in line with local guidance. Treatment of ACS: - Specialist initiation only, awaiting local guidance GPs may continue after specialist initiation. See Primary care guideline and prescribing information sheet Prophylaxis of VTE post hip and knee replacement surgery: Complete course will be supplied by hospital, to start upon discharge. Post-op whilst in-patient to be treated with parenteral anticoagulants If needed tablets can be crushed and dispersed in water.
04.11	Rivastigmine Exelon^®	Tablets 1.5mg and 3mg, Patches 4.6mg/24hours and 9.5mg/24hours Second Line for Mild to moderate Alzheimers disease Usual dose range 3-6mg twice daily (oral) and 4.6-9.5mg/24hour patch Max single dose 12mg (oral) and 9.5mg/24hr patch
15.01.05	Rocuronium Bromide
09.01.04	Romiplostim	Injection Restriced for use in line with NICE guidelines
04.09.01	Ropinirole
15.02	Ropivacaine Hydrochloride Naropin^®
11.08.02	Rose Bengal Minims^® Rose Bengal
02.12	Rosuvastatin	Tablet Restricted for 3rd line use by consultants and SpRs in hypercholesterolaemia clinic and cardiology
14.04	Rotavirus vaccine Rotarix^®
04.08.01	Rufinamide Inovelon^®	Tablets specialist use only
08.01.05	Ruxolitinib Jakavi^®
03.01.01.01	Salbutamol	Short acting beta agonist The following formulations are available on formulary: MDI, breath actuated MDI, DPI, nebules, tablets, MR capsules, injection 1st line = MDI + spacer 2nd line = CFC free breath actuated (Salamol Easi-Breathe - prescribe by brand) 3rd line = DPI (Easyhaler® Salbutamol) Nebules also available. Nebs may be diluted with 0.9% sodium chloride if needed
03.01.01.01	Salbutamol Ventmax^® SR
13.05.02	Salicyclic acid 2% and zinc 24% paste
13.07	Salicylic Acid 16.7% with Lactic Acid 16.7% Salactol^®
13.05.02	Salicylic Acid in White Soft Paraffin
03.01.01.01	Salmeterol	Long acting beta-agonist Evohaler (25mcg/dose) and Accuhaler (50mcg/dose) available
05.03.01	Saquinavir Invirase^®
01.07.02	Scheriproct^®	Suppositories and ointment Contains Cinchocaine 0.5% and prednisolone 0.19%
10.01.03	Secukinumab Cosentyx^®	For use in line with NICE guidance for treatment of: Psoriatic arthritis Ankylosing spondylitis For use in plaque psoriasis, see section 13.5.3
13.05.03	Secukinumab Cosentyx^®	For use in line with NICE guidance: TA350: Secukinumab for treating moderate to severe plaque psoriasis TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs
04.09.01	Selegiline Hydrochloride
09.05.05	Selenium Selenase^®	IV injection TPN team
06.01.02.03	Semaglutide Ozempic^®	First choice glucagon-like peptide-1 receptor agonist in parimary care
01.06.02	Senna	Tablet 7.5mg, Syrup 7.5mg/5ml
04.03.03	Sertraline	Tablets 50mg, 100mg Usual dose range 50-200mg daily Max daily dose 200mg Max single dose 200mg
09.05.02.02	Sevelamer Carbonate Renvela^®	Powder for oral suspension (sachets)
09.05.02.02	Sevelamer Hydrochloride Renagel^®	Tablets
15.01.02	Sevoflurane
13.09	Shampoos Ceanel Concentrate^®
02.05.01	Sildenafil	Tablet Secondary care only for pulmonary arterial hypertension (PAH) Revatio 20mg not stocked only keep sildenafil 25mg tablets. NOT for erectile dysfunction (ED)
07.04.05	Sildenafil
13.07	Silver Nitrate AVOCA^®	caustic pencil, tip containing silver nitrate 40%, potassoim nitrate 60%
13.10.01.01	Silver Sulfadiazine Flamazine^®	Cream
05.03.03.02	Simeprevir Olysio	First line for Genotype I and IV, in accordance with NHS England policy and NICE
01.01.01	Simeticone Infacol^®	For paediatrics and gastroenterology use
03.09.02	Simple Linctus, BP	Linctus Considered to be of limited clinical value. May be prescribed if appropriate in secondary care
03.09.02	Simple Linctus, Paediatric BP
02.12	Simvastatin	Tablets If needed tablets can be crushed and dispersed in water. Poorly soluble and degrades rapidly so crush thoroughly and give immediately
08.02.02	Sirolimus Rapamune^®
06.01.02.03	Sitagliptin Januvia^®	Tablets 25mg, 50mg and 100mg
09.08.01	Sodium Benzoate
09.02.01.03	Sodium Bicarbonate	Capsule (500mg = approx. 6 mmol each of Na+ and HCO3-) Capsules can be opened and the contents dispersed in water.
09.02.02.01	Sodium Bicarbonate	Available in multiple strengths: Sodium Bicarbonate 1.26% 500ml polyfusor (supply problems - probably not available) Sodium Bicarbonate 1.4% 500ml polyfusor (supply problems - probably not available) Sodium Bicarbonate 4.2% 10ml ampoules or 500ml polyfusor Sodium Bicarbonate 8.4% 10ml ampoules or 500ml polyfusor
12.01.03	Sodium Bicarbonate	Ear drops
24.01	Sodium Bicarbonate	2-3 mmol/kg by slow infusion 8.4%sodium bicarbonate = 1mmol/ml Dilute with water Monitor infusion site closely, extravasation can cause severe tiisue damage
18	Sodium calcium edetate
09.02.01.02	Sodium Chloride Slow Sodium^®
11.08.01	Sodium Chloride
11.08.01	Sodium Chloride Minims^® Saline	Eye drops 0.9% (preservative free)
13.11.01	Sodium Chloride 0.9%
11.08.01	Sodium Chloride 0.9% Solutions
09.02.02.01	Sodium Chloride Intravenous	Available in multiple strengths. Infusions: Sodium Chloride 0.45% infusion 500ml bag or polyfusor odium Chloride 0.9% infusion 50ml, 100ml, 250ml, 500ml, 1 litre Sodium Chloride 1.8% infusion 500ml Sodium Chloride 2.7% infusion 500ml polyfusor Ampoules: Sodium Chloride 0.9% injection 2ml, 5ml, 10ml and 20ml ampoules Sodium Chloride 30% injection 10ml
07.04.03	Sodium Citrate
07.04.04	Sodium Citrate
06.06.02	Sodium Clodronate	Tablet 800mg
11.04.02	Sodium Cromoglicate	Eye drops 2%
09.01.01.01	Sodium Feredetate Sytron^®	Elixir Sodium feredetate 190 mg equivalent to 27.5 mg of iron/5 mL
11.08.01	Sodium Hyaluronate Hylo-Forte^®
11.08.01	Sodium Hyaluronate Hylo-Tear^®	Eye drops
11.99.99.99	Sodium Hyaluronate
18	Sodium nitrite 3% Injection
02.05.01	Sodium Nitroprusside	Injection (secondary care only)
09.08.01	Sodium Phenybutyrate Ammonaps^®, Pheburane^®
24.01	Sodium Phosphate	0.5mmol (=1.6ml) bd. Prescribe as mmol stop at discharge
01.06.02	Sodium Picosulfate	Elixir 5mg/5ml, capsules (perles) 2.5mg
01.06.05	Sodium picosulphate with magnesium citrate Picolax^®, CitraFleet^®	Sachet
02.13	Sodium Tetradecyl Sulphate	Injection (secondary care only)
18	Sodium thiosulphate
04.02.03	Sodium valproate	Tablets 100mg (crushable), 200mg, 500mg, 200mg chrono, 300mg chrono, 500mg chrono Bipolar Affective Disorder usual dose range 500mg-1000mg in divided doses max daily dose 2000mg
04.08.01	Sodium Valproate Epilim^®
04.08.01	Sodium Valproate Epilim^® Intravenous
04.08.01	Sodium Valproate	Epilim^®, Epilim Chrono^®, Epilim^® injection
04.08.01	Sodium Valproate Epilim^® Chrono
10.01.03	Soldium Aurothomalate Myocrisin^®
07.04.02	Solifenacin Vesicare^®	Tablet 5mg and 10mg
06.05.01	Somatropin Saizen^®	Injection
02.04	Sotalol	Tablet Management of arrythmias. If needed tablets can be crushed and dispersed in water.
02.02.03	Spironolactone	Tablet 25mg, 50mg, 100mg, Oral Suspension 10mg/5ml Potasium sparing diuretic
24.01	Spironolactone	1 mg/kg bd initially Oral Potassium canreonate (Soldactone or Aldactone) 1-1.5mg/kg/dose (usually bd) can be given IV. Soldactone dilution: 200mg vial, add 2 ml H20; then take 1 ml of this ’Soldactone’ solution and add 9 mls 0.9% NaCl; this solution has 10mg ’Soldactone in 1 ml. Give the appropriate dose as slow bolus over 3 minutes. Potassium canreonate also comes as ’Aldactone’. Vial is 200mg in 10 mls. to make up, take 1 ml (=20mg) of solution and dilute to 20mls with 0.9% NaCl. This solution is 1mg/ml. Give the appropriate dose as slow bolus over 3 minutes.
07.03.03	Spremicidal Contraceptives Gygel^®
03.01.05	Standard range peak flow meter Mini-Wright^®	Suitable for adults and children 60-800 litres/minute low range also available for adults and children with severely restricted airflow 30-400 litres/minte
05.03.01	Stavudine Zerit^®
02.10.02	Streptokinase	Injection (secondary care only)
05.01.09	Streptomycin Sulphate
01.03.03	Sucralfate Antepsin^®	Tablet 1 gram, Suspension 1gram/5ml Interacts with enteral feeds and may block NG tubes March 2014 Current supply issues however limited stock available direct from manufacturer - pharmacy to order direct supplies
24.01	Sucrose 66%	Working weight <750g - 0.05ml (31.25mg) max tds 750g-999g - 0.1ml (62.5mg) max tds 1000g - 1499g -0.2mls (125mg) >1500g - 0.4mls (250mg)
01.05.01	Sulfasalazine	Tablets 500mg E/C and non E/C
10.01.03	Sulfasalazine
10.01.04	Sulfinpyrazone
04.02.01	Sulpiride	Tablet 200mg, 400mg and Liquid 200mg/5ml
04.07.04.01	Sumatriptan	Tablets 50mg, 100mg
08.01.05	Sunitinib Sutent^®	For use in line with NICE TA169, TA178, TA179 & TA449
15.01.05	Suxamethonium Chloride
24.01	Sytron Sodium Feredetate	0.5 mls tds from 1 month if not on mostly formula feeds
13.05.02	Tacalcitol Curatoderm^®
02.11	TachoSil Fibrinogen and thrombin	Fibrinogen and thrombin dried on to a collagen matrix Restricted to use by urology for use in robotic assisted laparoscopic, laparoscopic and open major urological surgery. Conditions include renal, prostate and bladder cancer Approved at DTC 12/07/2017 for 6 months use to assess whether superior to Surgicel
08.02.02	Tacrolimus Adoport^®, Prograf^®
13.05.03	Tacrolimus Protopic^®	Ointment 0.03%, Ointment 0.1%
08.02.02	Tacrolimus MR Advagraf^®
08.03.04.01	Tamoxifen
07.04.01	Tamsulosin	Capsule m/r 400 microgram
04.07.02	Tapentadol Palexia^®	Standard release 50mg (tablets) Modified release: Palexia SR 50mg, 100mg, 150mg, 200mg, 250mg Specialist initiation - for chronic pain in patients either unresponsive or unable to tolerate morphine, fentanyl, oxycodone and buprenorphine (i.e. fifth line strong opioid). Tapentadol can be used 3rd line only if the patient has not responded to morphine and buprenorphine and was showing symptoms of neuropathic pain.
05.01.07	Teicoplanin Targocid^®
04.01.01	Temazepam	Tablet 10mg and 20mg, Oral solution 10mg/5ml Second choice for insomnia Usual dose range: 10-20mg at night Max daily dose 20mg Max single dose 20mg CD storage requirements apply within BTHFT for ALL temazepam products
15.01.04.01	Temazepam
08.01.05	Temozolomide Temodal^®
02.10.02	Tenecteplase	Injection (secondary care only)
05.03.01	Tenofovir and Emtricitabine Truvada^®
05.03.01	Tenofovir Disproxil Viread^®
05.02	Terbinafine
13.10.02	Terbinafine	1% cream
03.01.01.01	Terbutaline	Short-acting beta-agonist Turbohaler (500mcg/dose) and Respules (2.5mg/ml) available Limited use where patient intolerant of salbutamol and in those patients whose condition is exacerbated by an aerosol
06.06.01	Teriparatide Forsteo^®	injection 250micrograms/ml
06.05.02	Terlipressin
06.04.02	Testosterone and Esters Nebido^®	Injection
06.04.02	Testosterone gel Tostran^®	Gel 2% (10 mg/metered application),
06.04.02	Testosterone injection Sustanon 250^®	Injection
14.05.02	Tetanus immunoglobulin
04.09.03	Tetrabenazine Xenazine^® 25
15.02	Tetracaine (Amethocaine)
24.01	Tetracaine 4% AMETOP^®	Indication: Local Anaestetic - Lumber Puncture(NeoClear) Dose: Apply contents of tube (or appropriate proportion) Administration: Apply to site of lumber puncture and cover with occlusive dressing; remove gel and dressing after 30 to 45 minutes for lumber puncture. Monitoring: Local skin reactions Storage & Supply: Available on NNU as a stock item. Stored in Fridge
11.07	Tetracaine Hydrochloride (Amethocaine Hydrochloride) Minims^®	Eye drops
06.05.01	Tetracosactide Synacthen^®	Injection 250micrograms/ml Short Synacthen test (30 min) 250 micrograms as a single dose Depot injection 1mg/ml
20	TETRAHYDROBIOPTERIN Tablets 10 mg
08.02.04	Thalidomide Pharmion^®
03.01.03	Theophylline Nuelin^® SA	Tablets m/r 250mg Prescribe by brand 175mg tablets not stocked at BTHFT
03.01.03	Theophylline Slo-Phyllin^®	Capsules m/r 60mg, 125mg and 250mg prescribe by brand If necessary Contents of the capsule (enteric-coated granules) may be sprinkled on to a spoonful of soft food (e.g. yoghurt) and swallowed without chewing
03.01.03	Theophylline Uniphyllin^® Continus	Tablets m/r 200mg, 300mg and 400mg Prescribe by brand May be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe in patients whose night or daytime sysmptoms persist despite other therapy, who are not currently recieving theophylline, total daily requirement may be added as single evening or morning dose
09.06.02	Thiamine Pabrinex^®	I/M High Potency injection, for intramuscular use only, ascorbic acid 500 mg, nicotinamide 160 mg, pyridoxine hydrochloride 50 mg, riboflavin 4 mg, thiamine hydrochloride 250 mg/7 mL. (in 2 amps) Excipients include benzyl alcohol (avoid in neonates) I/V High Potency injection, for intravenous use only, ascorbic acid 500 mg, anhydrous glucose 1 g, nicotinamide 160 mg, pyridoxine hydrochloride 50 mg, riboflavin 4 mg, thiamine hydrochloride 250 mg/10 mL. (in 2 × 5 mL amps) Wernickes Encephalopathy 2-3 pairs of ampoules three times a day for 2 to 4 days depending on response Prophylaxis of Wernickes Encephalopathy One pair of ampoules twice daily for at least 3 to 5 days
09.06.02	Thiamine	Tablets 50mg and 100mg Usual dose range: 50 to 100mg TDS
15.01.01	Thiopental
06.04.01.01	Tibolone Livial^®	Tablet 2.5mg
02.09	Ticagrelor	Position statement from cardiology to add
05.01.03	Tigecycline Tygacil^®
13.05.03	Tildrakizumab Ilumetri	To be prescribed as per NICE guidelines: TA575: Tildrakizumab for treating moderate to severe plaque psoriasis
11.06	Timolol	Eye drops 0.25% and 0.5%
05.04.02	Tinidazole
02.08.01	Tinzaparin Innohep^®	10,000 units/ml syringe for subcutaneous injection 20,000 units/ml syringe for subcutaneous injection 20,000 units/ml 2ml vial For prophylaxis and treatment of VTE
08.01.03	Tioguanine Lanvis^®
03.01.02	Tiotropium Spiriva^®	Inhalation powder 18microgram/dose, capsules for use with Handihaler Respimat device no longer recommended for prescribing
02.09	Tirofiban
05.01.04	Tobramycin
10.01.03	Tocilizumab RoActemra^®
01.05.03	Tofacitinib Xeljanz	To be used as per NICE guidelines: TA547: Tofacitinib for moderately to severely active ulcerative colitis Available as oral tablets
10.01.03	Tofacitinib Xelijang^®	Restricted for treatment of rheumatoid arthritis through patient access scheme NICE TA currently in development. Due Jan 2018
13.05.03	Tofacitinib Xeljanz	Oral tablets. As per NICE guidelines for psoriatic arthritis: TA543: Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs
24.01	Tolazoline	1 mg/kg IV over 10 mins then 0.2-2 mg/kg/hr Stock 25 mg/ml Weight x 50 mg tolazoline diluted to 50 mls in 5% dextrose 1ml/hr = 1mg/kg/hr
07.04.02	Tolterodine	Tablets 1mg, 2mg Capsules modified release 4mg
13.03	Topical local anaesthetics	Lidocaine 5% ointment
04.07.04.02	Topiramate
04.08.01	Topiramate
08.01.05	Topotecan Hycamtin^®
06.01.01.02	Toujeo^® Insulin glargine	Long acting recombinant human insulin analogue 300 units/ml pre-filled Solostar pen (1.5ml/pen) NOT bioequivalent to insulin glargine 100 units/ml - not directly interchangeable (see SPC) Restricted for initiation by diabetes team
04.07.02	Tramadol	Soluble tablet, Capsule, Slow release tablet, Injection
02.11	Tranexamic Acid	Tablet, Injection Topical solution (unlicensed). In an emergency 500mg/5ml injection can be used topically. If needed tablets can be crushed and dispersed in water.
12.03.04	Tranexamic Acid Mouthwash
08.01.05	Trastuzumab Herceptin^®
11.06	Travoprost Travatan^®	Eye drops 40micrograms/ml
11.06	Travoprost with Timolol DuoTrav^®	eye drops, travoprost 40micrograms and timolol 5mg/ml
04.03.01	Trazodone	Capsules and Tablets 50mg, 100mg and 150mg Liquid 50mg/5ml Usual dose range 100-300mg daily Max daily dose 600mg Max single dose 300mg
08.01.01	Treosulfan
06.01.01.02	Tresiba^® Insulin Degludec	Long acting recombinant human insulin analogue 100units/ml Penfill^® cartridges for Novo Nordisk^® devices 100units/ml FlexTouch^® prefilled pen 200units/ml FlexTouch^® prefilled pen Counter shows number of units regardless of strength Restricted to initiation by diabetes team
08.01.05	Tretinoin Vesanoid^®
06.03.02	Triamcinolone Kenalog^®	Intra-articular/intramuscular injection 40mg/ml
10.01.02.02	Triamcinolone Acetonide Adcortyl^®	Injection 10mg in 1mL
10.01.02.02	Triamcinolone Acetonide Kenalog^®	Injection: 40mg in 1mL Vial Pre filled syringe
12.02.01	Triamcinolone Acetonide Nasacort^®	Nasal spray 55micrograms per spray
09.08.01	Trientine Dihydrochloride
04.02.01	Trifluoperazine	Tablet 1mg, 5mg, Oral solution 1mg/5ml and 5mg/5ml First generation antipsychotic Usual dose range: 2.5mg twice daily initially Max daily dose: 50mg Max single dose: 25mg
04.06	Trifluoperazine
04.09.02	Trihexyphenidyl
05.01.08	Trimethoprim
05.01.13	Trimethoprim
24.01	Trimethoprim	Treatment mature babies 4 mg/kg bd oral Prophylaxis 2 mg/kg at night
04.03.01	Trimipramine Surmontil^®
01.03.03	Tripotassium Dicitratobismuthate De-Noltab®	Tablets 120mg An addition for second or third line H. pylori eradiction therapy
06.07.02	Triptorelin	Decapeptyl^®SR, Gonapeptyl Depot^®
08.03.04.02	Triptorelin Gonapeptyl Depot^®
08.03.04.02	Triptorelin- Decapeptyl^® SR
24.01	Trometamol THAM	Try 1.5mmol/kg (5ml) infused over 30mins and then reassess Usual stock is 0.3 Molar =0.3mmol/ml Watch for respiratory depression
20	TROMETAMOL (THAM) 125ML Injection 3.6% (0.3M)
11.05	Tropicamide	Mydriacyl^® 0.5% and 1% eye drops Minims^® Tropicamide 0.5% and 1% single use eye drops
07.04.02	Trospium	Tablet 20mg Capsule Modified release 60mg
04.03.04	Tryptophan	Tablets 500mg Adjunct for Adult Depression Usual dose range 3-6grams daily in three divided doses Max daily dose 6grams
07.03.05	Ulipristal EllaOne^®	Tablet 30mg, single dose effective if taken within 120 hours (5days) of unprotected intercourse
06.04.01.02	Ulipristal acetate
03.01.02	Umeclidinium Incruse Ellipta^®
03.01.04	Umeclidinium, vilanterol Anoro Ellipta^®	Dry powder inhaler Umeclidinium 55 micrograms/vilanterol 22 micrograms
13.02.01	Unguentum M^®	Cream
10.01.03	Upadacitinib Rinvoq	Upadacitinib is avaiable as 15mg prolonged release tablets. Upadacitinib can be prescribed as per NICE guidelines: NICE TA 665 - Upadacitinib for treating severe rheumatoid arthritis
06.05.01	Urofollitropin
01.09.01	Ursodeoxycholic acid Ursofalk^®	Tablet, Capsule, Suspension
24.01	Ursodeoxycholic Acid	10mg/kg twice daily
01.05.03	Ustekinumab Stelara^®	To be prescribed as per guidelines: TA456: Ustekinumab for moderately to severely active Crohn’s disease after previous treatment TA633: Ustekinumab for treating moderately to severely active ulcerative colitis In the treatment regimen, the first dose of Stelara is administered intravenously. The first subcutaneous administration of Stelara should take place at week 8 after the intravenous dose.
10.01.03	Ustekinumab
13.05.03	Ustekinumab Stelara	As per NICE guidelines: TA180: Ustekinumab for the treatment of adults with moderate to severe psoriasis TA340: Ustekinumab for treating active psoriatic arthritis TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
05.03.02.01	Valaciclovir Valtrex^®
05.03.02.02	Valganciclovir Valcyte^®
02.05.05.02	Valsartan, sacubitril Entresto^®	Film coated tablets Valsartan 26mg/sacubitril 24mg Valsartan 51mg/sacubitril 49mg Valsartan 103mg/sacubitril 97mg According to NICE TA388 for treating symptomatic chronic heart failure with reduced ejection fraction
05.01.07	Vancomycin
24.01	Vancomycin	15 mg/kg/dose bd infused over 1 hour Start every 24 hours if <28 weeks. Use 12 hourly if postmenstrual age >28/40 and 8 hourly if postmenstrual age >35/40. Use with caution if renal impairment 500mg vial dissolved in 4.8 mls water NEEDS FURTHER DILUTION TO 5 mg/ml by mixing 1ml of this concentrated solution with 19mls 5% dextrose. Levels: pre-dose(trough) 10-15 mcg/ml
04.10.02	Varenicline Champix^®
15.01.05	Vecuronium Bromide
01.05.03	Vedolizumab Entyvio^®	Vedolizumab is now available as an IV infusion and SC injection. For more information about dosing, contact the pharmacy or gastroenterology teams. To be used as per NICE guidelines: TA342: Vedolizumab for treating moderately to severely active ulcerative colitis TA352: Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
04.03.04	Venlafaxine	Tablets and capsules 37.5mg, 75mg, 150mg. Usual dose range 37.5-75mg twice daily Max daily dose 375mg
04.03.04	Venlafaxine Efexor^® XL	Tablets and Capsules, MODIFIED RELEASE 75mg, 150mg Usual dose range 75-225mg once daily Max daily dose 225mg Max single dose 225mg
02.06.02	Verapamil	Tablet, MR tablet, injection (secondary care only) If needed tablets can be crushed and dispersed in water. Do not crush MR formulations.
11.08.02	VibeX Rapid^® Riboflavin 0.1%	1.5ml pre-filled syringe Restricted to use by opthalmic surgeons for ‘epithelium-off’ photochemical corneal collagen cross-linkage (epithelium-off CXL) to treat progressive keratoconus or keratectasia after laser refractive surgery.
04.08.01	Vigabatrin Sabril^®
08.01.04	Vinblastine Sulphate
08.01.04	Vinblastine Sulphate Velbe^®
08.01.04	Vincristine Sulphate Oncovin^®
08.01.04	Vincristine Sulphate
08.01.04	Vindesine Sulphate Eldisine^®
08.01.04	Vinorelbine
08.01.04	Vinorelbine Navelbine^®
09.06.07	Vitamin and mineral supplements Forceval Soluble^®
09.06.07	Vitamin and mineral supplements Ketovite^®
09.06.07	Vitamin and mineral supplements Forceval^®
09.06.02	Vitamin B Tablets, Compound Strong	Tablets Usual dose : 2 three times daily
24.01	Vitamin E Tocopheryl Acetate	50mg once daily O/NG (not a /kg dose) 50mg=75units
24.01	Vitamin K Phytomendione	1mg once daily O/NG (not a /kg dose) Base Line clotting required and regularly monitor
09.06.01	Vitamins A and D
09.06.01	Vitamins A C and D Healthy Start Children's Vitamin Drops^®
11.08.01	VitA-POS	Eye ointment Retinol palmitate 250 units/g, white soft paraffin, light liquid paraffin, liquid paraffin, wool fat
05.02	Voriconazole Vfend^®
11.03.02	Voriconazole	Intravitreal injection For use by opthalmologists only
02.08.02	Warfarin	Tablets 0.5mg (white) 1mg (brown), 3mg (blue,) 5mg (pink), Suspension 1mg/ml (licensed) - £99 per 150ml If needed tablets can be crushed and dispersed in water.
12.02.02	Xylometazoline Otrivine^®	spray, for inpatient use, do not use for more than 7 days
01.07.02	Xyloproct^®	Ointment contains lidocaine 5% and hydrocortisone 0.275%
03.03.02	Zafirlukast Accolate^®	Tablet 20mg
13.02.02	Zinc and Caster Oil Ointment BP	Ointment
09.05.04	Zinc Sulphate	Effervescent Tablet 45mg elemental zinc
06.06.02	Zoledronic Acid	IV infusion 4mg/5ml (Zometa) for reduction of bone damage in advanced malignancies involving bone IV infusion 5mg/100ml (50micrograms/ml) Treatment of osteoporosis- Once yearly dose
04.01.01	Zolpidem	Tablets 5mg, 10mg Usual dose range: 5-10mg at night Max daily dose 10mg Max single dose 10mg
04.08.01	Zonisamide Zonegran^®
04.01.01	Zopiclone	Tablets 3.75mg, 7.5mg Usual dose range: 3.75-7.5mg at night Max daily dose 7.5mg Max single dose 7.5mg
04.02.01	Zuclopenthixol Clopixol^®	Tablet 2mg. 10mg and 25mg First generation antipsychotic Usual dose range: 20-50mg in divided doses Max daily dose: 150mg Max single dose: 50mg
04.02.01	Zuclopenthixol Acetate Clopixol Acuphase^®	Deep IM injection 200mg/ml snd 500mg/ml Max 600mg weekly
04.02.02	Zuclopenthixol Decanoate Clopixol^®	Depot Injection

Bradford Teaching Hospitals